Professor Sir K George Alberti

Publications


Journals

  • Williams DM; Martin RM; Davey Smith G; Alberti KG; Ben-Shlomo Y; McCarthy A. (2012). Associations of Infant Nutrition with Insulin Resistance Measures in Early Adulthood: Evidence from the Barry-Caerphilly Growth (BCG) Study. PLoS One. 7:e34161. DOI.
  • Zimmet P; Alberti KG. (26 Apr 2012). Surgery or medical therapy for obese patients with type 2 diabetes?. N Engl J Med. 366:1635-1636. DOI.
  • Harding JL; Soderberg S; Shaw JE; Zimmet PZ; Pauvaday V; Kowlessur S; Tuomilehto J; Alberti KG; et alJ Magliano D. (23 Feb 2012). All-cause cancer mortality over 15 years in multi-ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance. Int J Cancer. DOI.
  • Cameron AJ; Magliano DJ; Shaw JE; Zimmet PZ; Carstensen B; Alberti KG; Tuomilehto J; Barr EL; et alPauvaday VK; Kowlessur S; Söderberg S. (Apr 2012). The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol. 41:484-494. DOI.
  • Dixon JB; Zimmet P; Alberti KG; Mbanya JC; Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. (Dec 2011). Bariatric surgery for diabetes: the International Diabetes Federation takes a position. J Diabetes. 3:261-264. DOI.
  • Magliano DJ; Söderberg S; Zimmet PZ; Chen L; Joonas N; Kowlessur S; Larhubarbe J; Gaoneadry D; et alPauvaday V; Tuomilehto J; Alberti KG; Shaw JE. (Jan 2012). Explaining the increase of diabetes prevalence and plasma glucose in mauritius. Diabetes Care. 35:87-91. DOI.
  • Dixon JB; Zimmet P; Alberti KG; Rubino F. (1 Aug 2011). Bariatric surgery: an IDF statement for obese Type 2 diabetes. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA. 55:367-382. Author weblink.
  • Dixon JB; Zimmet P; Alberti KG; Rubino F. (1 Jul 2011). Bariatric surgery: an IDF statement for obese Type 2 diabetes. SURGERY FOR OBESITY AND RELATED DISEASES. 7:433-447. Author weblink DOI.
  • Dixon JB; Zimmet P; Alberti KG; Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. (Jul 2011). Bariatric surgery: an IDF statement for obese Type 2 diabetes. Surg Obes Relat Dis. 7:433-447. DOI.
  • Zimmet P; Alberti KG; Rubino F; Dixon JB. (9 Jul 2011). IDF's view of bariatric surgery in type 2 diabetes. Lancet. 378:108-110. DOI.
  • Dixon JB; Zimmet P; Alberti KG; Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. (Jun 2011). Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 28:628-642. DOI.
  • Holt RI; Young BS; Hitman GA; Alberti KG. (May 2011). The publication of Diabetes UK position statements and care recommendations. Diabet Med. 28:507. DOI.
  • Magliano DJ; Söderberg S; Zimmet PZ; Cartensen B; Balkau B; Pauvaday V; Kowlessur S; Tuomilehto J; et alAlberti KG; Shaw JE. (Sep 2010). Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care. 33:1983-1989. DOI.
  • Whincup PH; Nightingale CM; Owen CG; Rudnicka AR; Gibb I; McKay CM; Donin AS; Sattar N; et alAlberti KG; Cook DG. (Apr 2010). Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Med. 7:e1000263. DOI.
  • Lilja M; Rolandsson O; Shaw JE; Pauvaday V; Cameron AJ; Tuomilehto J; Alberti KG; Zimmet PZ; et alSöderberg S. (May 2010). Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk. Int J Obes (Lond). 34:878-885. DOI.
  • Eckel RH; Alberti KG; Grundy SM; Zimmet PZ. (16 Jan 2010). The metabolic syndrome. Lancet. 375:181-183. DOI.
  • Al-Maatouq M; Al-Arouj M; Assaad SH; Assaad SN; Azar ST; Hassoun AA; Jarrah N; Zatari S; et alAlberti KG. (Jan 2010). Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin. Int J Clin Pract. 64:149-159. DOI.
  • Cameron AJ; Sicree RA; Zimmet PZ; Alberti KG; Tonkin AM; Balkau B; Tuomilehto J; Chitson P; et alShaw JE. (Oct 2010). Cut-points for waist circumference in Europids and South Asians. Obesity (Silver Spring). 18:2039-2046. DOI.
  • Simmons RK; Alberti KG; Gale EA; Colagiuri S; Tuomilehto J; Qiao Q; Ramachandran A; Tajima N; et alBrajkovich Mirchov I; Ben-Nakhi A; Reaven G; Hama Sambo B; Mendis S; Roglic G. (Apr 2010). The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 53:600-605. DOI.
  • Penn L; White M; Oldroyd J; Walker M; Alberti KG; Mathers JC. (2009). Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health. 9:342. DOI.
  • Alberti KG; Eckel RH; Grundy SM; Zimmet PZ; Cleeman JI; Donato KA; Fruchart JC; James WP; et alLoria CM; Smith SC; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. (20 Oct 2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120:1640-1645. DOI.
  • Cameron AJ; Zimmet PZ; Shaw JE; Alberti KG. (Mar 2009). The metabolic syndrome: in need of a global mission statement. Diabet Med. 26:306-309. DOI.
  • Nyamdorj R; Qiao Q; Söderberg S; Pitkäniemi JM; Zimmet PZ; Shaw JE; Alberti KG; Pauvaday VK; et alChitson P; Kowlessur S; Tuomilehto J. (Feb 2009). BMI compared with central obesity indicators as a predictor of diabetes incidence in Mauritius. Obesity (Silver Spring). 17:342-348. DOI.
  • Hyvärinen M; Qiao Q; Tuomilehto J; Laatikainen T; Heine RJ; Stehouwer CD; Alberti KG; Pyörälä K; et alZethelius B; Stegmayr B; DECODE Study Group. (Feb 2009). Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria. Diabetes Care. 32:348-354. DOI.
  • Stappenbeck R; Hodson AW; Skillen AW; Agius L; Alberti KG. (1990). Optimized methods to measure acetoacetate, 3-hydroxybutyrate, glycerol, alanine, pyruvate, lactate and glucose in human blood using a centrifugal analyser with a fluorimetric attachment. J Automat Chem. 12:213-220. DOI.
  • Zhang L; Qiao Q; Tuomilehto J; Hammar N; Alberti KG; Eliasson M; Heine RJ; Stehouwer CD; et alRuotolo G; DECODE Study Group. (Dec 2008). Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. Diabetes Res Clin Pract. 82:364-377. DOI.
  • Cameron AJ; Boyko EJ; Sicree RA; Zimmet PZ; Söderberg S; Alberti KG; Tuomilehto J; Chitson P; et alShaw JE. (Dec 2008). Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring). 16:2707-2716. DOI.
  • Boyko EJ; Shaw JE; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG. (Sep 2008). A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius. J Hypertens. 26:1742-1749. DOI.
  • Miller MA; McTernan PG; Harte AL; Silva NF; Strazzullo P; Alberti KG; Kumar S; Cappuccio FP. (Apr 2009). Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis. 203:494-502. DOI.
  • Shaw JE; Punjabi NM; Wilding JP; Alberti KG; Zimmet PZ; International Diabetes Federation Taskforce on Epidemiology and Prevention. (Jul 2008). Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 81:2-12. DOI.
  • Alberti KG; Zimmet PZ. (22 Mar 2008). Should we dump the metabolic syndrome? No. BMJ. 336:641. DOI.
  • Alberti KG; Bailey CJ; Blonde L; Felton AM; Zimmet P; Global Partnership for Effective Diabetes Management. (Dec 2007). Partnering with governments and other institutions: driving change in diabetes care. Int J Clin Pract Suppl. 38-46. DOI.
  • Cameron AJ; Zimmet PZ; Soderberg S; Alberti KG; Sicree R; Tuomilehto J; Chitson P; Shaw JE. (Dec 2007). The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med. 24:1460-1469. DOI.
  • Bouguerra R; Alberti H; Smida H; Salem LB; Rayana CB; El Atti J; Achour A; Gaigi S; et alSlama CB; Zouari B; Alberti KG. (Nov 2007). Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population. Diabetes Obes Metab. 9:859-868. DOI.
  • Zimmet P; Alberti KG; Kaufman F; Tajima N; Silink M; Arslanian S; Wong G; Bennett P; et alShaw J; Caprio S; IDF Consensus Group. (Oct 2007). The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 8:299-306. DOI.
  • Alberti KG. (Sep 2007). Screening and diagnosis of prediabetes: where are we headed?. Diabetes Obes Metab. 9 Suppl 1:12-16. DOI.
  • Söderberg S; Zimmet P; Tuomilehto J; Chitson P; Gareeboo H; Alberti KG; Shaw JE. (Jul 2007). Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond). 31:1126-1133. DOI.
  • Gray CS; Hildreth AJ; Sandercock PA; O'Connell JE; Johnston DE; Cartlidge NE; Bamford JM; James OF; et alAlberti KG; GIST Trialists Collaboration. (May 2007). Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 6:397-406. DOI.
  • Alberti KG; Zimmet P; Shaw J. (May 2007). International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 24:451-463. DOI.
  • Bailey CJ; Alberti KG. (Mar 2007). Cardio-diabetes alliances. Diab Vasc Dis Res. 4:6-7. DOI.
  • Cooke MW; Alberti KG. (Jan 2007). Emergency care for children--the next steps. Arch Dis Child. 92:6-8. DOI.
  • Oldroyd JC; Yallop J; Fischbacher C; Bhopal R; Chamley J; Ayis S; Alberti KG; Unwin NC. (Jan 2007). Transient and persistent impaired glucose tolerance and progression to diabetes in South Asians and Europeans: new, large studies are a priority. Diabet Med. 24:98-99. DOI.
  • Alberti KG; Zimmet P; Shaw J. (Dec 2006). Reply. Diabet Med. 23:1385-1386. Publisher weblink DOI.
  • Unwin N; McLarty D; Machibya H; Aspray T; Tamin B; Carlin L; Patel S; Walker M; et alAlberti KG. (Sep 2006). Changes in blood pressure and lipids associated with rural to urban migration in Tanzania. J Hum Hypertens. 20:704-706. DOI.
  • Tapp RJ; Zimmet PZ; Harper CA; McCarty DJ; Chitson P; Tonkin AM; Söderberg S; Taylor HR; et alAlberti KG; Tuomilehto J; Shaw JE. (Sep 2006). Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract. 73:298-303. DOI.
  • Setel PW; Rao C; Hemed Y; Whiting DR; Yang G; Chandramohan D; Alberti KG; Lopez AD. (Aug 2006). Core verbal autopsy procedures with comparative validation results from two countries. PLoS Med. 3:e268. DOI.
  • Alberti KG; Zimmet P. (Aug 2006). The metabolic syndrome: time to reflect. Curr Diab Rep. 6:259-261.
  • Unwin N; Alberti KG. (Jul 2006). Chronic non-communicable diseases. Ann Trop Med Parasitol. 100:455-464. DOI.
  • Alberti KG; Zimmet P; Shaw J. (May 2006). Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 23:469-480. DOI.
  • Shaw JE; Zimmet PZ; Alberti KG. (May 2006). Point: impaired fasting glucose: The case for the new American Diabetes Association criterion. Diabetes Care. 29:1170-1172. DOI.
  • Oldroyd JC; Unwin NC; White M; Mathers JC; Alberti KG. (May 2006). Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract. 72:117-127. DOI.
  • Setel PW; Whiting DR; Hemed Y; Chandramohan D; Wolfson LJ; Alberti KG; Lopez AD. (May 2006). Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health. 11:681-696. DOI.
  • Whincup P; Gilg J; Owen C; Cook D; Alberti KG. (Mar 2006). Authors' reply. Diabet Med. 23:336. Publisher weblink DOI.
  • Pearce MS; Unwin NC; Parker L; Alberti KG. (Mar 2006). Life course determinants of insulin secretion and sensitivity at age 50 years: the Newcastle thousand families study. Diabetes Metab Res Rev. 22:118-125. DOI.
  • Zimmet PZ; Alberti KG. (Jan 2006). Introduction: Globalization and the non-communicable disease epidemic. Obesity (Silver Spring). 14:1-3. DOI.
  • Alberti KG; Zimmet P; Shaw J; IDF Epidemiology Task Force Consensus Group. (24 Sep 2005). The metabolic syndrome--a new worldwide definition. Lancet. 366:1059-1062. DOI.
  • Whincup PH; Gilg JA; Owen CG; Odoki K; Alberti KG; Cook DG. (Sep 2005). British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabet Med. 22:1275-1277. DOI.
  • Zimmet PZ; Alberti KG; Shaw JE. (15 Aug 2005). Mainstreaming the metabolic syndrome: a definitive definition. Med J Aust. 183:175-176.
  • Söderberg S; Zimmet P; Tuomilehto J; de Courten M; Dowse GK; Chitson P; Gareeboo H; Alberti KG; et alShaw JE. (Jan 2005). Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet Med. 22:61-68. DOI.
  • Pearce MS; Unwin NC; Relton CL; Alberti KG; Parker L. (2005). Lifecourse determinants of fasting and post-challenge glucose at age 50 years: the Newcastle Thousand Families Study. Eur J Epidemiol. 20:915-923. DOI.
  • Alberti KG. (6 Nov 2004). Emergency care networks. BMJ. 329:1057-1058. DOI.
  • Sobngwi E; Mbanya JC; Unwin NC; Porcher R; Kengne AP; Fezeu L; Minkoulou EM; Tournoux C; et alGautier JF; Aspray TJ; Alberti K. (Aug 2004). Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. Int J Epidemiol. 33:769-776. DOI.
  • Söderberg S; Zimmet P; Tuomilehto J; de Courten M; Dowse GK; Chitson P; Stenlund H; Gareeboo H; et alAlberti KG; Shaw J. (Jul 2004). High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med. 256:37-47. DOI.
  • Amiel SA; Alberti KG. (22 May 2004). Inhaled insulin. BMJ. 328:1215-1216. DOI.
  • Genuth S; Alberti KG; Bennett P. (1 Feb 2004). Start lifestyle changes at lower glycemic levels to delay diabetes progression. GERIATRICS. 59:15-16. Author weblink.
  • Syed AA; Irving JA; Redfern CP; Hall AG; Unwin NC; White M; Bhopal RS; Alberti KG; et alWeaver JU. (Jan 2004). Low prevalence of the N363S polymorphism of the glucocorticoid receptor in South Asians living in the United Kingdom. J Clin Endocrinol Metab. 89:232-235.
  • Barbato A; Cappuccio FP; Folkerd EJ; Strazzullo P; Sampson B; Cook DG; Alberti KG. (Jan 2004). Metabolic syndrome and renal sodium handling in three ethnic groups living in England. Diabetologia. 47:40-46. DOI.
  • Gray CS; Scott JF; French JM; Alberti KG; O'Connell JE. (Jan 2004). Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing. 33:71-77.
  • Genuth S; Alberti KG; Bennett P; Buse J; Defronzo R; Kahn R; Kitzmiller J; Knowler WC; et alLebovitz H; Lernmark A; Nathan D; Palmer J; Rizza R; Saudek C; Shaw J; Steffes M; Stern M; Tuomilehto J; Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (Nov 2003). Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 26:3160-3167.
  • Williams JW; Zimmet PZ; Shaw JE; de Courten MP; Cameron AJ; Chitson P; Tuomilehto J; Alberti KG. (Nov 2003). Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter?. Diabet Med. 20:915-920.
  • Zimmet P; Shaw J; Alberti KG. (Sep 2003). Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med. 20:693-702.
  • Parker L; Lamont DW; Unwin N; Pearce MS; Bennett SM; Dickinson HO; White M; Mathers JC; et alAlberti KG; Craft AW. (May 2003). A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years. Diabet Med. 20:406-415.
  • Fischbacher CM; Bhopal R; Blackwell CC; Ingram R; Unwin NC; White M; Alberti KG. (1 Apr 2003). IgG is higher in South Asians than Europeans: does infection contribute to ethnic variation in cardiovascular disease?. Arterioscler Thromb Vasc Biol. 23:703-704. DOI.
  • Alberti KG. (Mar 2003). Skillmix: an advance or an excuse?. Emerg Med J. 20:112-113.
  • Mswia R; Lewanga M; Moshiro C; Whiting D; Wolfson L; Hemed Y; Alberti KG; Kitange H; et alMtasiwa D; Setel P. (2003). Community-based monitoring of safe motherhood in the United Republic of Tanzania. Bull World Health Organ. 81:87-94.
  • Fischbacher CM; Bhopal R; Rutter MK; Unwin NC; Marshall SM; White M; Alberti KG. (Jan 2003). Microalbuminuria is more frequent in South Asian than in European origin populations: a comparative study in Newcastle, UK. Diabet Med. 20:31-36.
  • Emberson JR; Whincup PH; Walker M; Thomas M; Alberti KG. (Sep 2002). Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann Clin Biochem. 39:493-501. DOI.
  • Unwin N; Shaw J; Zimmet P; Alberti KG. (Sep 2002). Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 19:708-723.
  • Hayes L; White M; Unwin N; Bhopal R; Fischbacher C; Harland J; Alberti KG. (Sep 2002). Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population. J Public Health Med. 24:170-178.
  • Wannamethee SG; Shaper AG; Perry IJ; Alberti KG. (Jul 2002). Alcohol consumption and the incidence of type II diabetes. J Epidemiol Community Health. 56:542-548.
  • Sobngwi E; Mbanya JC; Unwin NC; Kengne AP; Fezeu L; Minkoulou EM; Aspray TJ; Alberti KG. (Jul 2002). Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord. 26:1009-1016. DOI.
  • Ham C; Alberti KG. (6 Apr 2002). The medical profession, the public, and the government. BMJ. 324:838-842.
  • Whincup PH; Gilg JA; Papacosta O; Seymour C; Miller GJ; Alberti KG; Cook DG. (16 Mar 2002). Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ. 324:635.
  • Alberti KG. (Feb 2002). Have we got the new diagnostic criteria for diabetes and impaired glucose states right? Almost. Curr Diab Rep. 2:1-2.
  • Fischbacher CM; White M; Bhopal R; Unwin N; Alberti KG. (Jan 2002). Newcastle heart project. J Epidemiol Community Health. 56:79.
  • Zimmet P; Alberti KG; Shaw J. (13 Dec 2001). Global and societal implications of the diabetes epidemic. Nature. 414:782-787. DOI.
  • Sobngwi E; Mbanya JC; Unwin NC; Aspray TJ; Alberti KG. (Dec 2001). Development and validation of a questionnaire for the assessment of physical activity in epidemiological studies in Sub-Saharan Africa. Int J Epidemiol. 30:1361-1368.
  • Fischbacher CM; Bhopal R; Unwin N; White M; Alberti KG. (Oct 2001). The performance of the Rose angina questionnaire in South Asian and European origin populations: a comparative study in Newcastle, UK. Int J Epidemiol. 30:1009-1016.
  • Fischbacher CM; Bhopal R; Unwin N; Walker M; White M; Alberti KG. (Sep 2001). Maternal transmission of type 2 diabetes varies by ethnic group: cross-sectional survey of Europeans and South Asians. Diabetes Care. 24:1685-1686.
  • Alberti KG. (Aug 2001). Treating type 2 diabetes - today's targets, tomorrow's goals. Diabetes Obes Metab. 3 Suppl 1:3-10.
  • Alberti KG. (Aug 2001). Treating type 2 diabetes--today's targets, tomorrow's goals. Diabetes Obes Metab. 3 Suppl 1:S3-10.
  • Kriska AM; Pereira MA; Hanson RL; de Courten MP; Zimmet PZ; Alberti KG; Chitson P; Bennett PH; et alNarayan KM; Knowler WC. (Jul 2001). Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care. 24:1175-1180.
  • Piatti PM; Monti LD; Valsecchi G; Magni F; Setola E; Marchesi F; Galli-Kienle M; Pozza G; et alAlberti KG. (May 2001). Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care. 24:875-880.
  • Patel S; Bhopal R; Unwin N; White M; Alberti KG; Yallop J. (May 2001). Mismatch between perceived and actual overweight in diabetic and non-diabetic populations: a comparative study of South Asian and European women. J Epidemiol Community Health. 55:332-333.
  • Fischbacher C; Bhopal R; Patel S; White M; Unwin N; Alberti KG. (21 Apr 2001). Anaemia in Chinese, South Asian, and European populations in Newcastle upon Tyne: cross sectional study. BMJ. 322:958-959.
  • Oldroyd JC; Unwin NC; White M; Imrie K; Mathers JC; Alberti KG. (Apr 2001). Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months. Diabetes Res Clin Pract. 52:29-43.
  • Alberti KG. (3 Mar 2001). Medical errors: a common problem. BMJ. 322:501-502.
  • Scott JF; Robinson GM; French JM; O'Connell JE; Alberti KG; Gray CS. (Mar 2001). Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycaemia. J Neurol Neurosurg Psychiatry. 70:401-404.
  • Moshiro C; Mswia R; Alberti KG; Whiting DR; Unwin N; AMMP Project Team. (Mar 2001). The importance of injury as a cause of death in sub-Saharan Africa: results of a community-based study in Tanzania. Public Health. 115:96-102. DOI.
  • Waterworth DM; Talmud PJ; Humphries SE; Wicks PD; Sagnella GA; Strazzullo P; Alberti KG; Cook DG; et alCappuccio FP. (Feb 2001). Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups. Diabetologia. 44:245-248. DOI.
  • Hodge AM; Boyko EJ; de Courten M; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG. (Jan 2001). Leptin and other components of the Metabolic Syndrome in Mauritius--a factor analysis. Int J Obes Relat Metab Disord. 25:126-131.
  • Unwin N; Setel P; Rashid S; Mugusi F; Mbanya JC; Kitange H; Hayes L; Edwards R; et alAspray T; Alberti KG. (2001). Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda?. Bull World Health Organ. 79:947-953.
  • White M; Harland JO; Bhopal RS; Unwin N; Alberti KG. (Jan 2001). Smoking and alcohol consumption in a UK Chinese population. Public Health. 115:62-69. DOI.
  • Setel P; Whiting D; Hemed Y; Alberti KG. (Dec 2000). Educational status is related to mortality at the community level in three areas of Tanzania, 1992-1998. J Epidemiol Community Health. 54:936-937.
  • Aspray TJ; Mugusi F; Rashid S; Whiting D; Edwards R; Alberti KG; Unwin NC; Essential Non-Communicable Disease Health Intervention Project. (Nov 2000). Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg. 94:637-644.
  • Boyko EJ; de Courten M; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG. (Sep 2000). Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care. 23:1242-1248.
  • Wannamethee SG; Shaper AG; Alberti KG. (24 Jul 2000). Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med. 160:2108-2116.
  • Rashid S; Aspray TJ; Edwards R; Mugusi F; Whiting D; Unwin NC; Setel P; Alberti KG. (1 Jul 2000). The pitfalls of measuring changes in smoking habits. TROPICAL DOCTOR. 30:160-161.
  • Rashid S; Aspray TJ; Edwards R; Mugusi F; Whiting D; Unwin NC; Setel P; Alberti KG. (Jul 2000). The pitfalls of measuring changes in smoking habits. Essential NCD Health Intervention Project Team. Trop Doct. 30:160-161.
  • Walker RW; McLarty DG; Masuki G; Kitange HM; Whiting D; Moshi AF; Massawe JG; Amaro R; et alMhina A; Alberti KG. (Jun 2000). Age specific prevalence of impairment and disability relating to hemiplegic stroke in the Hai District of northern Tanzania. Adult Morbidity and Mortality Project. J Neurol Neurosurg Psychiatry. 68:744-749.
  • Walker RW; McLarty DG; Kitange HM; Whiting D; Masuki G; Mtasiwa DM; Machibya H; Unwin N; et alAlberti KG. (13 May 2000). Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet. 355:1684-1687.
  • Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO. (May 2000). Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. J Clin Endocrinol Metab. 85:1912-1917.
  • Alberti KG. (29 Apr 2000). Multicentre research ethics committees: has the cure been worse than the disease? No, but idiosyncracies and obstructions to good research must be removed. BMJ. 320:1157-1158.
  • Edwards R; Unwin N; Mugusi F; Whiting D; Rashid S; Kissima J; Aspray TJ; Alberti KG. (Feb 2000). Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 18:145-152.
  • Lamont D; Parker L; White M; Unwin N; Bennett SM; Cohen M; Richardson D; Dickinson HO; et alAdamson A; Alberti KG; Craft AW. (29 Jan 2000). Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study. BMJ. 320:273-278.
  • Shaw JE; Zimmet PZ; Hodge AM; de Courten M; Dowse GK; Chitson P; Tuomilehto J; Alberti KG. (Jan 2000). Impaired fasting glucose: how low should it go?. Diabetes Care. 23:34-39.
  • Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O. (Nov 1999). Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia. 42:1314-1323. DOI.
  • Patel S; Unwin N; Bhopal R; White M; Harland J; Ayis SA; Watson W; Alberti KG. (Oct 1999). A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med. 16:853-860.
  • Perry IJ; Wannamethee SG; Shaper AG; Alberti KG. (Aug 1999). Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up. Int J Epidemiol. 28:735-741.
  • Bhopal R; Unwin N; White M; Yallop J; Walker L; Alberti KG; Harland J; Patel S; et alAhmad N; Turner C; Watson B; Kaur D; Kulkarni A; Laker M; Tavridou A. (24 Jul 1999). Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 319:215-220.
  • Alberti KG; Bennett JR. (3 Jul 1999). Proposed appraisal system and political correctness. Correspondent rather than the royal college may have lost touch with reality. BMJ. 319:53.
  • Nyholm B; Orskov L; Hove KY; Gravholt CH; Møller N; Alberti KG; Moyses C; Kolterman O; et alSchmitz O. (Jul 1999). The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism. 48:935-941.
  • Arthur MJ; Alberti KG. (Jul 1999). Training in academic medicine: a way forward for the new millennium. A discussion document from the Academic Medicine Committee of the Royal College of Physicians. J R Coll Physicians Lond. 33:359-364.
  • Alberti KG; Ward JD. (26 Jun 1999). Caring for and about acute general medicine. Expansion in consultant numbers is needed. BMJ. 318:1759.
  • Unwin N; Mugusi F; Aspray T; Whiting D; Edwards R; Mbanya JC; Sobgnwi E; Rashid S; et alAlberti KG. (May 1999). Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health. 113:141-146.
  • Parker L; Lamont DW; Wright CM; Cohen MA; Alberti KG; Craft AW. (3 Apr 1999). Mothering skills and health in infancy: the Thousand Families study revisited. Lancet. 353:1151-1152.
  • Scott JF; Robinson GM; French JM; O'Connell JE; Alberti KG; Gray CS. (Apr 1999). Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 30:793-799.
  • Alberti KG. (Apr 1999). Severe diabetic ketoacidosis: a comment. Diabet Med. 16:350-351.
  • Alberti KG; Daly ME; Robinson A; Marshall SM; Mathers JC. (Apr 1999). The short insulin tolerance test is safe and reproducible. Diabet Med. 16:352-353.
  • Shaw JE; Zimmet PZ; de Courten M; Dowse GK; Chitson P; Gareeboo H; Hemraj F; Fareed D; et alTuomilehto J; Alberti KG. (Mar 1999). Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?. Diabetes Care. 22:399-402.
  • Scott JF; Robinson GM; French JM; O'Connell JE; Alberti KG; Gray CS. (30 Jan 1999). Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet. 353:376-377.
  • Boyko EJ; Decourten MP; Chitson P; Zimmet PZ; Alberti KG. (1 Jan 1999). A prospective study of risk of type 2 diabetes and impaired glucose tolerance in relation to features of the metabolic syndrome among Mauritians. DIABETES. 48:A173-A173. Author weblink.
  • Shaw JE; Hodge AM; de Courten M; Dowse GK; Gareeboo H; Tuomilehto J; Alberti KG; Zimmet PZ. (Nov 1998). Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes Res Clin Pract. 42:131-139.
  • Alberti KG; Gray DP. (Nov 1998). The care of diabetes. Diabet Med. 15 Suppl 3:S3-S4. DOI.
  • Hodge AM; de Courten MP; Dowse GK; Zimmet PZ; Collier GR; Gareeboo H; Chitson P; Fareed D; et alHemraj F; Alberti KG; Tuomilehto J. (Sep 1998). Do leptin levels predict weight gain?--A 5-year follow-up study in Mauritius. Mauritius Non-communicable Disease Study Group. Obes Res. 6:319-325.
  • Alberti KG. (29 Aug 1998). Improving pay and working conditions is better than merely rewarding healthcare teams. BMJ. 317:602.
  • Pereira MA; Kriska AM; Collins VR; Dowse GK; Tuomilehto J; Alberti KG; Gareeboo H; Hemraj F; et alPurran A; Fareed D; Brissonnette G; Zimmet PZ. (15 Jul 1998). Occupational status and cardiovascular disease risk factors in the rapidly developing, high-risk population of Mauritius. Am J Epidemiol. 148:148-159.
  • Walker R; Unwin N; Alberti KG. (4 Jul 1998). Hypertension treatment and control in Sub-saharan Africa. Burden of cerebrovascular disease will increase as more people survive to old age. BMJ. 317:76-77.
  • Unwin N; Alberti KG; Bhopal R; Harland J; Watson W; White M. (Jul 1998). Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association. Diabet Med. 15:554-557. DOI.
  • Alberti KG; Zimmet PZ. (Jul 1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 15:539-553. DOI.
  • Scott JF; Gray CS; O'Connell JE; Alberti KG. (Jul 1998). Glucose and insulin therapy in acute stroke; why delay further?. QJM. 91:511-515.
  • Alberti KG. (Jul 1998). Impaired glucose tolerance: what are the clinical implications?. Diabetes Res Clin Pract. 40 Suppl:S3-S8.
  • Alberti KG; Zimmet PZ. (Jul 1998). New diagnostic criteria and classification of diabetes--again?. Diabet Med. 15:535-536. DOI.
  • Daly ME; Vale C; Walker M; Littlefield A; Alberti KG; Mathers JC. (Jun 1998). Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr. 67:1186-1196.
  • Alberti KG. (May 1998). Lipids and diabetes: a fatal combination?. Diabet Med. 15:359. DOI.
  • Jimenez JT; Palacios M; Cañete F; Barriocanal LA; Medina U; Figueredo R; Martinez S; de Melgarejo MV; et alWeik S; Kiefer R; Alberti KG; Moreno-Azorero R. (Apr 1998). Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay. Diabet Med. 15:334-338. DOI.
  • Lamont DW; Parker L; Cohen MA; White M; Bennett SM; Unwin NC; Craft AW; Alberti KG. (Mar 1998). Early life and later determinants of adult disease: a 50 year follow-up study of the Newcastle Thousand Families cohort. Public Health. 112:85-93.
  • Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG. (Mar 1998). Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus. Metabolism. 47:250-256.
  • Dowse GK; Humphrey AR; Collins VR; Plehwe W; Gareeboo H; Fareed D; Hemraj F; Taylor HR; et alTuomilehto J; Alberti KG; Zimmet PZ. (1 Mar 1998). Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 147:448-457.
  • Zimmet PZ; Collins VR; de Courten MP; Hodge AM; Collier GR; Dowse GK; Alberti KG; Tuomilehto J; et alHemraj F; Gareeboo H; Chitson P; Fareed D. (Feb 1998). Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group. Int J Obes Relat Metab Disord. 22:171-177.
  • Nyholm B; Mengel A; Nielsen S; Skjaerbaek CB; Møller N; Alberti KG; Schmitz OE. (19 Jan 1998). [Insulin resistance among relatives of patients with NIDDM. Significance of physical fitness and muscle metabolism]. Ugeskr Laeger. 160:410-415.
  • Lowes W; Walker M; Alberti KG; Agius L. (8 Jan 1998). Hexokinase isoenzymes in normal and cirrhotic human liver: suppression of glucokinase in cirrhosis. Biochim Biophys Acta. 1379:134-142.
  • Mgonda YM; Ramaiya KL; Swai AB; McLarty DG; Alberti KG. (Jan 1998). Insulin resistance and hypertension in non-obese Africans in Tanzania. Hypertension. 31:114-118.
  • Poulter NR; Alberti KG; Beevers DG; Betteridge DJ; Campbell RW. (20 Dec 1997). Drug therapy for coronary heart disease: the Sheffield table. Lancet. 350:1852-1853.
  • Alberti KG; London DR. (20 Dec 1997). Specialist training in the UK. Lancet. 350:1850.
  • Harland JO; Unwin N; Bhopal RS; White M; Watson B; Laker M; Alberti KG. (Dec 1997). Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Community Health. 51:636-642.
  • Daly ME; Vale C; Walker M; Alberti KG; Mathers JC. (Nov 1997). Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications. Am J Clin Nutr. 66:1072-1085.
  • Brunner EJ; Marmot MG; Nanchahal K; Shipley MJ; Stansfeld SA; Juneja M; Alberti KG. (Nov 1997). Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia. 40:1341-1349. DOI.
  • Tavridou A; Unwin NC; Laker MF; White M; Alberti KG. (31 Oct 1997). Serum concentrations of vitamins A and E in impaired glucose tolerance. Clin Chim Acta. 266:129-140.
  • Caprio S; Wong S; Alberti KG; King G. (Oct 1997). Cardiovascular complications of diabetes. Diabetologia. 40 Suppl 3:B78-B82.
  • Humphriss DB; Stewart MW; Berrish TS; Barriocanal LA; Trajano LR; Ashworth LA; Brown MD; Miller M; et alAvery PJ; Alberti KG; Walker M. (Oct 1997). Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia. 40:1185-1190. DOI.
  • Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD. (Oct 1997). The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM. Diabetologia. 40:1125-1134. DOI.
  • Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO. (Sep 1997). Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback. J Clin Endocrinol Metab. 82:2996-3004.
  • Harland JO; White M; Bhopal RS; Raybould S; Unwin NC; Alberti KG. (Sep 1997). Identifying Chinese populations in the UK for epidemiological research: experience of a name analysis of the FHSA register. Family Health Services Authority. Public Health. 111:331-337.
  • Walker M; Berrish TS; Stewart MW; Humphriss DB; Barriocanal L; Alberti KG. (Aug 1997). Metabolic heterogeneity in impaired glucose tolerance. Metabolism. 46:914-917.
  • Zimmet PZ; Alberti KG. (Jul 1997). The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet. 350 Suppl 1:SI1-SI4.
  • Newkirk JE; Taylor RW; Howell N; Bindoff LA; Chinnery PF; Alberti KG; Turnbull DM; Walker M. (Jun 1997). Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population. Diabet Med. 14:457-460. DOI.
  • Unwin N; Harland J; White M; Bhopal R; Winocour P; Stephenson P; Watson W; Turner C; et alAlberti KG. (Apr 1997). Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health. 51:160-166.
  • Whincup PH; Cook DG; Adshead F; Taylor SJ; Walker M; Papacosta O; Alberti KG. (Mar 1997). Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11-year-old children. Diabetologia. 40:319-326. DOI.
  • de Courten M; Zimmet P; Hodge A; Collins V; Nicolson M; Staten M; Dowse G; Alberti KG. (Mar 1997). Hyperleptinaemia: the missing link in the, metabolic syndrome?. Diabet Med. 14:200-208. DOI.
  • Farrer M; Skinner JS; Albers CJ; Alberti KG; Adams PC. (Mar 1997). Outcome after coronary artery surgery in women and men in the north of England. QJM. 90:203-211.
  • Hodge AM; Westerman RA; de Courten MP; Collier GR; Zimmet PZ; Alberti KG. (Jan 1997). Is leptin sensitivity the link between smoking cessation and weight gain?. Int J Obes Relat Metab Disord. 21:50-53.
  • Yajnik CS; Sardesai BS; Bhat DS; Naik SS; Raut KN; Shelgikar KM; Orskov H; Alberti KG; et alHockaday TD. (Jan 1997). Ketosis resistance in fibrocalculous pancreatic diabetes: II. Hepatic ketogenesis after oral medium-chain triglycerides. Metabolism. 46:1-4.
  • Alberti KG. (Jan 1997). The costs of non-insulin-dependent diabetes mellitus. Diabet Med. 14:7-9. DOI.
  • McLarty DG; Unwin N; Kitange HM; Alberti KG. (Nov 1996). Diabetes mellitus as a cause of death in sub-Saharan Africa: results of a community-based study in Tanzania. The Adult Morbidity and Mortality Project. Diabet Med. 13:990-994. DOI.
  • Alberti KG. (Nov 1996). The clinical implications of impaired glucose tolerance. Diabet Med. 13:927-937. DOI.
  • Uusitalo U; Feskens EJ; Tuomilehto J; Dowse G; Haw U; Fareed D; Hemraj F; Gareeboo H; et alAlberti KG; Zimmet P. (26 Oct 1996). Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey. BMJ. 313:1044-1046.
  • Ezenwaka CE; Akanji AO; Unwin N; Alberti KG. (Oct 1996). Are body mass or insulin resistance independently associated with cardiovascular risk factors in non-diabetic elderly Nigerians?. Diabet Med. 13:874-881. DOI.
  • Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O. (Oct 1996). GLP-1 does not not acutely affect insulin sensitivity in healthy man. Diabetologia. 39:1227-1232.
  • Stewart MW; Albers C; Laker MF; Hattemer A; Alberti KG. (Oct 1996). Self-monitoring of triglycerides by type 2 diabetic patients: variability in fasting and postprandial levels. Diabet Med. 13:894-897. DOI.
  • Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER. (Aug 1996). Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse. Diabetologia. 39:961-969.
  • Briceño I; Barriocanal LA; Papiha SS; Ashworth LA; Gómez A; Bernal JE; Alberti KG; Walker M. (Aug 1996). Lack of diabetes in rural Colombian Amerindians. Diabetes Care. 19:900-901.
  • Perry IJ; Wannamethee SG; Whincup PH; Shaper AG; Walker MK; Alberti KG. (1 Aug 1996). Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol. 144:224-234.
  • Shmueli E; Miell JP; Stewart M; Alberti KG; Record CO. (Jul 1996). High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. Hepatology. 24:127-133. DOI.
  • Nyholm B; Mengel A; Nielsen S; Skjaerbaek C; Møller N; Alberti KG; Schmitz O. (Jul 1996). Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia. 39:813-822.
  • Hodge AM; Dowse GK; Collins VR; Alberti KG; Gareeboo H; Tuomilehto J; Zimmet PZ. (Jun 1996). Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians. J Cardiovasc Risk. 3:263-270.
  • Zimmet P; Alberti KG. (Jun 1996). Leptin: is it important in diabetes?. Diabet Med. 13:501-503. DOI.
  • Hodge AM; Dowse GK; Alberti KG; Tuomilehto J; Gareeboo H; Zimmet PZ. (May 1996). Relationship of insulin resistance to weight gain in nondiabetic Asian Indian, Creole, and Chinese Mauritians. Mauritius Non-communicable Disease Study Group. Metabolism. 45:627-633.
  • Møller N; Nielsen S; Nyholm B; Pørksen N; Alberti KG; Weeke J. (Apr 1996). Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol (Oxf). 44:453-459.
  • Hussain MA; Schmitz O; Christiansen JS; Christensen NJ; Alberti KG; Froesch ER. (Apr 1996). IGF-I alters skeletal muscle substrate metabolism and blunts recovery from insulin-induced hypoglycemia. Am J Physiol. 270:E545-E551.
  • Nyholm B; Møller N; Gravholt CH; Orskov L; Mengel A; Bryan G; Moyses C; Alberti KG; et alSchmitz O. (Mar 1996). Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 81:1083-1089.
  • Taylor RW; Printz RL; Armstrong M; Granner DK; Alberti KG; Turnbull DM; Walker M. (Mar 1996). Variant sequences of the Hexokinase II gene in familial NIDDM. Diabetologia. 39:322-328.
  • Armstrong M; Haldane F; Taylor RW; Humphriss D; Berrish T; Stewart MW; Turnbull DM; Alberti KG; et alWalker M. (Feb 1996). Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitus. Diabet Med. 13:133-138. DOI.
  • Hodge AM; Dowse GK; Gareeboo H; Tuomilehto J; Alberti KG; Zimmet PZ. (Feb 1996). Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord. 20:137-146.
  • Kitange HM; Machibya H; Black J; Mtasiwa DM; Masuki G; Whiting D; Unwin N; Moshiro C; et alKlima PM; Lewanga M; Alberti KG; McLarty DG. (27 Jan 1996). Outlook for survivors of childhood in sub-Saharan Africa: adult mortality in Tanzania. Adult Morbidity and Mortality Project. BMJ. 312:216-220.
  • McLarty D; Alberti KG; Unwin N. (27 Jan 1996). Tropical medicine for the 21st century. Tropical medicine should become specialty of "health in developing countries". BMJ. 312:247-248.
  • Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG. (Jan 1996). Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients. Diabetologia. 39:103-112.
  • Alberti KG. (1996). Impaired glucose tolerance--fact or fiction. Diabet Med. 13:S6-S8.
  • Catalano C; Winocour PH; Parlongo S; Gibb I; Gillespie S; Alberti KG. (1996). Measures of tubular function in normoalbuminuric insulin-dependent diabetic patients and their relationship with sodium lithium countertransport activity. Nephron. 73:613-618.
  • Christie AW; McCormick DK; Emmison N; Kraemer FB; Alberti KG; Yeaman SJ. (Jan 1996). Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes. Diabetologia. 39:45-53.
  • Cooper BG; Matthews JN; Alberti KG. (23 Dec 1995). Resting energy expenditure, substrate use, and video tapes. BMJ. 311:1664-1665.
  • Dowse GK; Gareeboo H; Alberti KG; Zimmet P; Tuomilehto J; Purran A; Fareed D; Chitson P; et alCollins VR. (11 Nov 1995). Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ. 311:1255-1259.
  • Walker M; Taylor RW; Stewart MW; Bindoff LA; Shearing PA; Anyaoku V; Jackson MJ; Humphriss DB; et alJohnston DG; Alberti KG. (Nov 1995). Insulin and proinsulin secretion in subjects with abnormal glucose tolerance and a mitochondrial tRNA(Leu(UUR)) mutation. Diabetes Care. 18:1507-1509.
  • Alberti KG. (9 Sep 1995). Local research ethics committees. BMJ. 311:639-640.
  • Farrer M; Fulcher G; Albers CJ; Neil HA; Adams PC; Alberti KG. (Aug 1995). Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year. Metabolism. 44:1016-1027.
  • Hodge AM; Dowse GK; Zimmet PZ; Gareeboo H; Westerman RA; Tuomilehto J; Alberti KG. (Jul 1995). Factors associated with impaired vibration perception in Mauritians with normal and abnormal glucose tolerance. Mauritius NCD Study Group. J Diabetes Complications. 9:149-157.
  • Stewart MW; Humphriss DB; Berrish TS; Barriocanal LA; Trajano LR; Alberti KG; Walker M. (Jul 1995). Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care. 18:1020-1022.
  • Berrish TS; Hetherington CS; Alberti KG; Walker M. (Jun 1995). Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Diabetologia. 38:699-704.
  • Brierley EJ; Broughton DL; James OF; Alberti KG. (Jun 1995). Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM. 88:439-445.
  • Møller N; Bagger JP; Schmitz O; Jørgensen JO; Ovesen P; Møller J; Alberti KG; Orskov H. (Jun 1995). Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm. J Clin Endocrinol Metab. 80:1789-1793.
  • Unwin N; Skillen A; Alberti KG. (May 1995). The Yellow Springs analyser gives lower results than other glucose oxidase methods of glucose measurement. Ann Clin Biochem. 32 ( Pt 3):329-331.
  • Farrer M; Albers CJ; Neil HA; Adams PC; Laker MF; Alberti KG. (Apr 1995). Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys. Diabet Med. 12:325-329.
  • Cooper BG; White JE; Ashworth LA; Alberti KG; Gibson GJ. (Apr 1995). Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep. 18:172-179.
  • Mugusi F; Ramaiya KL; Chale S; Swai AB; McLarty DG; Alberti KG. (Mar 1995). Blood pressure changes in diabetes in urban Tanzania. Acta Diabetol. 32:28-31.
  • Abildgaard N; Orskov L; Petersen JA; Alberti KG; Schmitz O; Møller N. (Mar 1995). Forearm substrate exchange during hyperinsulinaemic hypoglycaemia in normal man. Diabet Med. 12:218-223.
  • Stewart MW; Dyer RG; Alberti KG; Laker MF. (Mar 1995). The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia. Diabet Med. 12:250-257.
  • Tong P; Thomas T; Berrish T; Humphriss D; Barriocanal L; Stewart M; Walker M; Wilkinson R; et alAlberti KG. (11 Feb 1995). Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet. 345:357-358.
  • Dyer RG; Hetherington CS; Alberti KG; Laker MF. (6 Jan 1995). Simultaneous measurement of phytosterols (campesterol and beta-sitosterol) and 7-ketocholesterol in human lipoproteins by capillary column gas chromatography. J Chromatogr B Biomed Appl. 663:1-7.
  • Shmueli E; Record CO; Alberti KG. (Jan 1995). Insulin independent glucose uptake in cirrhosis. Hepatology. 21:265-266.
  • Piatti PM; Monti LD; Caumo A; Santambrogio G; Magni F; Galli-Kienle M; Costa S; Pontiroli AE; et alAlberti KG; Pozza G. (Jan 1995). The continuous low dose insulin and glucose infusion test: a simplified and accurate method for the evaluation of insulin sensitivity and insulin secretion in population studies. J Clin Endocrinol Metab. 80:34-40.
  • Jones SC; Alberti KG. (1 Dec 1994). Pancreatic cancer and diabetes. N Engl J Med. 331:1527.
  • Alberti KG. (Nov 1994). [Gliclazide: review of metabolic and vascular action]. Diabete Metab. 20:341-348.
  • Alberti KG. (Nov 1994). [Problems raised by the definition and epidemiology of type 2 (non-insulin-dependent) diabetes throughout the world]. Diabete Metab. 20:315-324.
  • Alberti KG; Gries FA; Jervell J; Krans HM. (Nov 1994). A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group. Diabet Med. 11:899-909.
  • Hawthorne GC; Ashworth L; Alberti KG. (Oct 1994). The effect of laparoscopic cholecystectomy on insulin sensitivity. Horm Metab Res. 26:474-477. DOI.
  • Alberti KG. (24 Sep 1994). Insulin dependent diabetes mellitus: a lethal disease in the developing world. BMJ. 309:754-755.
  • Taylor RW; Stewart MW; Avery PJ; Humphriss DB; Alberti KG; Turnbull DM; Walker M. (6 Aug 1994). Apolipoprotein E and familial non-insulin-dependent diabetes mellitus. Lancet. 344:406.
  • Azad K; Parkin JM; Court S; Laker MF; Alberti KG. (Aug 1994). Circulating lipids and glycaemic control in insulin dependent diabetic children. Arch Dis Child. 71:108-113.
  • Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG. (Aug 1994). Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb. 14:1272-1283.
  • Schmitz O; Pedersen SB; Mengel A; Pørksen N; Bak J; Møller N; Richelsen B; Alberti KG; et alButler PC; Orskov H. (Jul 1994). Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects. Metabolism. 43:842-846.
  • Jackson MJ; Bindoff LA; Weber K; Wilson JN; Ince P; Alberti KG; Turnbull DM. (Jul 1994). Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care. 17:728-733.
  • Alberti KG. (Jul 1994). Diabetes and the National Health Service Research and Development Program. Diabet Med. 11:526-527.
  • Wright RA; Flapan AD; Alberti KG; Ludlam CA; Fox KA. (Jul 1994). Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol. 24:67-73.
  • Zimmet PZ; Collins VR; Dowse GK; Alberti KG; Tuomilehto J; Knight LT; Gareeboo H; Chitson P; et alFareed D. (May 1994). Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabet Med. 11:388-396.
  • Azad K; Court S; Parkin JM; Laker MF; Alberti KG. (May 1994). Lipid levels in schoolchildren in north east England: effects of feeding and age. Ann Clin Biochem. 31 ( Pt 3):233-239.
  • Walker M; Berrish TS; James AR; Alberti KG. (Apr 1994). Effect of hyperinsulinaemia on the function of the pituitary-adrenal axis in healthy man. Clin Endocrinol (Oxf). 40:493-497.
  • Alberti KG; McLarty DG; Swai AB. (19 Mar 1994). Hypoglycaemia in paediatric admissions in Mozambique. Lancet. 343:733.
  • Deeb LC; Tan MH; Alberti KG. (Mar 1994). Insulin availability among International Diabetes Federation member associations. Report of the Task Force on Insulin Distribution. Diabetes Care. 17:220-223.
  • Farrer M; Winocour PH; Evans K; Neil HA; Laker MF; Kesteven P; Alberti KG. (Mar 1994). Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures. Diabetes Res Clin Pract. 23:111-119.
  • Shmueli E; Stewart M; Alberti KG; Record CO. (Feb 1994). Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis. Hepatology. 19:322-328.
  • Wright RA; Flapan AD; Stenhouse F; Simpson C; Flint L; Boon NA; Alberti KG; Reimersma RA; et alFox KA. (Feb 1994). Hyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function. Q J Med. 87:131-138.
  • Alberti KG. (1994). Insulin: availability and cost. World Health Forum. 15:376-377.
  • Kitange H; Swai AB; Masuki G; Kilima PM; Alberti KG; McLarty DG. (1994). Perinatal mortality in rural Tanzania. World Health Forum. 15:82-84.
  • Walker M; Trajano LR; Alberti KG; Kendall-Taylor P. (1994). Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms. Thyroid. 4:73-76.
  • Stewart MW; Laker MF; Alberti KG. (1994). The contribution of lipids to coronary heart disease in diabetes mellitus. J Intern Med Suppl. 736:41-46.
  • Wright RA; Perrie AM; Stenhouse F; Alberti KG; Riemersma RA; MacGregor IR; Boon NA. (1994). The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease. Eur J Clin Pharmacol. 46:279-282.
  • Alberti KG; Baylis PH. (11 Dec 1993). Undergraduate medical education. Core curriculum should remain flexible. BMJ. 307:1566.
  • Alberti KG. (4 Dec 1993). Preventing insulin dependent diabetes mellitus. BMJ. 307:1435-1436.
  • Tuomilehto J; Dabee J; Karvonen M; Dowse GK; Gareeboo H; Virtala E; Tiihonen M; Alberti KG; et alZimmet PZ. (Dec 1993). Incidence of IDDM in Mauritian children and adolescents from 1986 to 1990. Diabetes Care. 16:1588-1591.
  • Jørgensen JO; Møller J; Alberti KG; Schmitz O; Christiansen JS; Orskov H; Moller N. (Dec 1993). Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab. 77:1589-1596.
  • Ovesen P; Moller J; Ingerslev HJ; Jørgensen JO; Mengel A; Schmitz O; Alberti KG; Moller N. (Dec 1993). Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 77:1636-1640.
  • Kitange HM; Swai AB; McLarty DG; Alberti KG. (Dec 1993). Schistosomiasis prevalence after administration of praziquantel to school children in Melela village, Morogoro region, Tanzania. East Afr Med J. 70:782-786.
  • Collins VR; Dowse GK; Zimmet PZ; Tuomilehto J; Alberti KG; Gareeboo H; Nan L. (Dec 1993). Serum insulin and ECG abnormalities suggesting coronary heart disease in the populations of Mauritius and Nauru: cross-sectional and longitudinal associations. J Clin Epidemiol. 46:1373-1393.
  • Bahru Y; Kesteven P; Alberti KG; Walker M. (Nov 1993). Decreased plasminogen activator inhibitor-1 activity in newly diagnosed type 2 diabetic patients following dietary modification. Diabet Med. 10:802-806.
  • Møller N; Møller J; Jørgensen JO; Ovesen P; Schmitz O; Alberti KG; Christiansen JS. (Nov 1993). Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans. Clin Endocrinol (Oxf). 39:577-581.
  • Winocour PH; Catalano C; Thomas TH; Wilkinson R; Alberti KG. (Nov 1993). Increased red cell sodium lithium countertransport activity, total exchangeable sodium, and hormonal control of sodium balance in normoalbuminuric type 1 diabetes. Diabet Med. 10:825-832.
  • Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG. (2 Oct 1993). Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ. 307:832-836.
  • Shmueli E; Alberti KG; Record CO. (Oct 1993). Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance?. J Intern Med. 234:397-400.
  • Alberti KG. (Oct 1993). Problems related to definitions and epidemiology of type 2 (non-insulin-dependent) diabetes mellitus: studies throughout the world. Diabetologia. 36:978-984.
  • Nielsen S; Schmitz O; Møller N; Pørksen N; Klausen IC; Alberti KG; Mogensen CE. (Oct 1993). Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 36:1079-1086.
  • Dowse GK; Zimmet PZ; Alberti KG; Brigham L; Carlin JB; Tuomilehto J; Knight LT; Gareeboo H. (Oct 1993). Serum insulin distributions and reproducibility of the relationship between 2-hour insulin and plasma glucose levels in Asian Indian, Creole, and Chinese Mauritians. Mauritius NCD Study Group. Metabolism. 42:1232-1241.
  • Walker M; Shmueli E; Daley SE; Cooper BG; Alberti KG. (Sep 1993). Do nonesterified fatty acids regulate skeletal muscle protein turnover in humans?. Am J Physiol. 265:E357-E361.
  • Harris PE; Walker M; Clark F; Home PD; Alberti KG. (Sep 1993). Forearm muscle metabolism in primary hypothyroidism. Eur J Clin Invest. 23:585-588.
  • Kitange HM; Swai AB; Masuki G; Kilima PM; Alberti KG; McLarty DG. (Aug 1993). Coronary heart disease risk factors in sub-Saharan Africa: studies in Tanzanian adolescents. J Epidemiol Community Health. 47:303-307.
  • Swai AB; McLarty DG; Kitange HM; Kilima PM; Tatalla S; Keen N; Chuwa LM; Alberti KG. (Aug 1993). Low prevalence of risk factors for coronary heart disease in rural Tanzania. Int J Epidemiol. 22:651-659.
  • Stewart MW; Laker MF; Dyer RG; Game F; Mitcheson J; Winocour PH; Alberti KG. (Jul 1993). Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb. 13:1046-1052.
  • Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO. (Jun 1993). A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462. DOI.
  • Shmueli E; Orskov H; Alberti KG; Record CO. (Jun 1993). Octreotide treatment does not improve impaired glucose uptake in cirrhosis. Horm Metab Res. 25:317-320. DOI.
  • Walker M; Agius L; Orskov H; Alberti KG. (May 1993). Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: effect of nonesterified fatty acids. Metabolism. 42:601-608.
  • Catalano C; Winocour PH; Gillespie S; Gibb I; Alberti KG. (Apr 1993). Effect of posture and acute glycaemic control on the excretion of retinol-binding protein in normoalbuminuric insulin-dependent diabetic patients. Clin Sci (Lond). 84:461-467.
  • Lutale JK; Justesen A; Swai AB; Alberti KG; McLarty DF. (Apr 1993). Glucose tolerance during and after pregnancy in nondiabetic women in an urban population in Tanzania. Diabetes Care. 16:575-577.
  • Fulcher GR; Walker M; Farrer M; Johnson AS; Alberti KG. (Mar 1993). Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism. 42:308-314.
  • Møller N; Pørksen N; Ovesen P; Alberti KG. (Mar 1993). Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans. Horm Metab Res. 25:175-179. DOI.
  • Swai AB; McLarty DG; Alberti KG. (Mar 1993). IDDM in sub-Saharan Africa. Diabet Med. 10:188.
  • Dowse GK; Zimmet PZ; Alberti KG. (Mar 1993). Infant nutrition and subsequent risk of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 36:267-268.
  • Dowse GK; Collins VR; Alberti KG; Zimmet PZ; Tuomilehto J; Chitson P; Gareeboo H. (Mar 1993). Insulin and blood pressure levels are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. The Mauritius Non-communicable Disease Study Group. J Hypertens. 11:297-307.
  • Yajnik CS; Naik SS; Bhat DS; Joshi VM; Shelgikar KM; Alberti KG; Hockaday TD. (Mar 1993). The relationship between obesity, plasma immunoreactive insulin concentration and blood pressure in newly diagnosed Indian type 2 diabetic patients. Diabet Med. 10:146-151.
  • Hawdon JM; Aynsley-Green A; Alberti KG; Ward Platt MP. (Mar 1993). The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Arch Dis Child. 68:274-279.
  • Berrish TS; Elliott C; Cooper BG; Reed JW; Orskov H; Alberti KG; Walker M. (Mar 1993). The role of plasma non-esterified fatty acids during exercise in type 2 diabetes mellitus. Diabet Med. 10:152-158.
  • Stewart MW; Laker MF; Alberti KG. (20 Feb 1993). Effects of self monitoring of triglyceride concentrations in non-insulin dependent diabetes. BMJ. 306:493.
  • Walker M; Rodham D; Fulcher GR; Clayton B; Farrer M; Alberti KG. (13 Feb 1993). Bioelectrical impedance and body composition. Lancet. 341:448.
  • Davis SN; Piatti PM; Monti L; Brown M; Hetherington C; Antsiferov M; Sobey W; Hales CN; et alOrskov H; Alberti KG. (Feb 1993). The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man. Diabetes Res Clin Pract. 19:103-113.
  • Tuomilehto J; Li N; Dowse G; Gareeboo H; Chitson P; Fareed D; Min Z; Alberti KG; et alZimmet P. (Feb 1993). The prevalence of coronary heart disease in the multi-ethnic and high diabetes prevalence population of Mauritius. J Intern Med. 233:187-194.
  • Davis SN; Monti L; Piatti PM; Ansiferov M; Hetherington C; Brown M; Orskov H; Branch W; et alHales CN; Alberti KG. (1993). Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man. Acta Diabetol. 30:29-35.
  • Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG. (Jan 1993). Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients. Diabetologia. 36:52-56.
  • Davis SN; Monti L; Piatti PM; Moller N; Ng L; Coppack S; May M; Brown MD; et alOrskov H; Alberti KG. (1993). Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques. Diabetes Res. 23:1-18.
  • Alberti KG. (Jan 1993). Interhealth: the WHO integrated programme for community health in non-communicable diseases. J R Coll Physicians Lond. 27:65-69.
  • Robertson DA; Alberti KG; Dowse GK; Zimmet P; Tuomilehto J; Gareeboo H. (Jan 1993). Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group. Diabet Med. 10:56-60.
  • Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG. (Jan 1993). Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects. Metabolism. 42:30-35.
  • Fulcher GR; Catalano C; Walker M; Farrer M; Thow J; Whately-Smith CR; Alberti KG. (Dec 1992). A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus. Diabet Med. 9:908-914.
  • Deerochanawong C; Home PD; Alberti KG. (Dec 1992). A survey of lower limb amputation in diabetic patients. Diabet Med. 9:942-946.
  • Akinmokun A; Harris P; Home PD; Alberti KG. (Nov 1992). Is diabetes always diabetes?. Diabetes Res Clin Pract. 18:131-136.
  • Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG. (Nov 1992). Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes. 41:1400-1408.
  • Davis SN; Ansiferov M; Hetherington C; Brown M; Branch WJ; Hales CN; Orskov H; Alberti KG. (Nov 1992). The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitus. J Clin Endocrinol Metab. 75:1282-1288.
  • Swai AB; Kitange HM; Masuki G; Kilima PM; Alberti KG; McLarty DG. (31 Oct 1992). Is diabetes mellitus related to undernutrition in rural Tanzania?. BMJ. 305:1057-1062.
  • Swai AB; Mclarty DG; Mtinangi BL; Tatala S; Kitange HM; Mlingi N; Rosling H; Howlett WP; et alBrubaker GR; Alberti KG. (Oct 1992). Diabetes is not caused by cassava toxicity. A study in a Tanzanian community. Diabetes Care. 15:1378-1385.
  • Shmueli E; Record CO; Alberti KG. (Oct 1992). Liver disease, carbohydrate metabolism and diabetes. Baillieres Clin Endocrinol Metab. 6:719-743.
  • Robertson DA; Tunbridge FK; John WG; Home PD; Alberti KG. (12 Sep 1992). Diagnostic confusion in diabetes with persistence of fetal haemoglobin. BMJ. 305:635-637.
  • Ashworth L; Gibb I; Alberti KG. (Aug 1992). HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem. 38:1479-1482.
  • Davis SN; Monti L; Piatti PM; Brown M; Hetherington C; Orskov H; Sobey W; Hales CN; et alAlberti KG. (Jul 1992). Dose-response characteristics of human proinsulin and insulin in non-insulin-dependent diabetic humans. Am J Physiol. 263:E28-E35.
  • Winocour PH; Thomas TH; Brown L; Laker MF; Wilkinson R; Alberti KG. (30 Jun 1992). Serum triglyceride and insulin levels are associated with erythrocyte sodium-lithium counter-transport activity in normoglycaemic individuals. Clin Chim Acta. 208:193-203.
  • Li N; Tuomilehto J; Dowse G; Alberti KG; Zimmet P; Min Z; Chitson P; Gareeboo H; et alChonghua Y; Fareed D. (20 Jun 1992). Electrocardiographic abnormalities and associated factors in Chinese living in Beijing and in Mauritius. The Mauritius Non-Communicable Disease Study Group. BMJ. 304:1596-1601.
  • LI N; TUOMILEHTO J; DOWSE G; ALBERTI KG; ZIMMET P; MIN Z; CHITSON P; GAREEBOO H; et alYOU CH; FAREED D. (20 Jun 1992). ELECTROCARDIOGRAPHIC ABNORMALITIES AND ASSOCIATED FACTORS IN CHINESE LIVING IN BEIJING AND IN MAURITIUS. BRITISH MEDICAL JOURNAL. 304:1596-1601. Author weblink.
  • Akinmokun A; Selby PL; Ramaiya K; Alberti KG. (Jun 1992). The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med. 9:432-437.
  • Farrer M; Game FL; Adams PC; Laker MF; Alberti KG. (15 May 1992). A simple, sensitive technique for classification of apolipoprotein(a) isoforms by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Clin Chim Acta. 207:215-225.
  • Fulcher GR; Walker M; Catalano C; Farrer M; Alberti KG. (May 1992). Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox. Clin Sci (Lond). 82:565-571.
  • Møller N; Schmitz O; Jøorgensen JO; Astrup J; Bak JF; Christensen SE; Alberti KG; Weeke J. (May 1992). Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab. 74:1012-1019.
  • Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG. (May 1992). Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis. Metabolism. 41:465-470.
  • Alberti KG; Johnson AB; Taylor R. (May 1992). Gliclazide: metabolic and vascular effects--a perspective. Metabolism. 41:40-45.
  • Winocour PH; Masud T; Clark F; Cooper BG; Laker MF; Alberti KG. (May 1992). Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study. Postgrad Med J. 68:371-375.
  • Snowden C; Houlston R; Laker MF; Kesteven P; Alberti KG; Humphries SE. (May 1992). Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics. Dis Markers. 10:159-167.
  • Hartman ML; Veldhuis JD; Johnson ML; Lee MM; Alberti KG; Samojlik E; Thorner MO. (Apr 1992). Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab. 74:757-765.
  • Marshall SM; Shearing PA; Alberti KG. (Apr 1992). Micral-test strips evaluated for screening for albuminuria. Clin Chem. 38:588-591.
  • Davis SN; Piatti PM; Monti L; Möller N; Ng LL; Coppack S; Antsiferov M; Brown MD; et alAlberti KG. (Mar 1992). A comparison of four methods for assessing in vivo beta-cell function in normal, obese and non-insulin-dependent diabetic man. Diabetes Res. 19:107-117.
  • Winocour PH; Harland JO; Millar JP; Laker MF; Alberti KG. (Mar 1992). Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 93:71-81.
  • Winocour PH; Kaluvya S; Ramaiya K; Brown L; Millar JP; Farrer M; Neil HA; Laker MF; et alAlberti KG. (Mar 1992). Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women. Arterioscler Thromb. 12:393-402.
  • Monti LD; Piatti PM; Home PD; Tomson C; Alberti KG. (Mar 1992). The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type 1 (insulin-dependent) diabetic patients. Diabetes Res Clin Pract. 15:237-244.
  • Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD. (Feb 1992). The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test. Diabetes Res Clin Pract. 15:149-156.
  • Davis SN; Thompson CJ; Peak M; Brown MD; Alberti KG. (Jan 1992). Effects of human insulin on insulin binding antibody production in nondiabetic subjects. Diabetes Care. 15:124-126.
  • Connolly CC; Steiner KE; Stevenson RW; Neal DW; Williams PE; Alberti KG; Cherrington AD. (Dec 1991). Regulation of glucose metabolism by norepinephrine in conscious dogs. Am J Physiol. 261:E764-E772.
  • Tunbridge FK; Home PD; Murphy M; Alberti KG. (Nov 1991). Does flexibility at mealtimes disturb blood glucose control on a multiple insulin injection regimen?. Diabet Med. 8:833-838.
  • Walker M; Fulcher GR; Marsiaj H; Orskov H; Alberti KG. (Nov 1991). The independent effect of ketone bodies on forearm glucose metabolism in normal man. Scand J Clin Lab Invest. 51:605-613.
  • Kawo NG; Msengi AE; Swai AB; Orskov H; Alberti KG; McLarty DG. (Nov 1991). The metabolic effects of quinine in children with severe and complicated Plasmodium falciparum malaria in Dar es Salaam. Trans R Soc Trop Med Hyg. 85:711-713.
  • Zimmet PZ; Collins VR; Dowse GK; Alberti KG; Tuomilehto J; Gareeboo H; Chitson P. (15 Oct 1991). The relation of physical activity to cardiovascular disease risk factors in Mauritians. Mauritius Noncommunicable Disease Study Group. Am J Epidemiol. 134:862-875.
  • Ramaiya KL; Swai AB; McLarty DG; Alberti KG. (Oct 1991). Impaired glucose tolerance and diabetes mellitus in Hindu Indian immigrants in Dar es Salaam. Diabet Med. 8:738-744.
  • Connolly CC; Steiner KE; Stevenson RW; Neal DW; Williams PE; Alberti KG; Cherrington AD. (Oct 1991). Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs. Am J Physiol. 261:E466-E472.
  • Velázquez E; Winocour PH; Kesteven P; Alberti KG; Laker MF. (Oct 1991). Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med. 8:752-758.
  • Alberti KG. (28 Sep 1991). Role of diabetes. BMJ. 303:769-772.
  • Walker M; Fulcher GR; Sum CF; Orskov H; Alberti KG. (Sep 1991). Effect of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans. Am J Physiol. 261:E304-E311.
  • Nan L; Tuomilehto J; Dowse G; Zimmet P; Gareeboo H; Chitson P; Korhonen HJ; Alberti KG; et alFareed D. (Sep 1991). Prevalence and medical care of hypertension in four ethnic groups in the newly-industrialized nation of Mauritius. J Hypertens. 9:859-866.
  • Walker M; Cooper BG; Elliott C; Reed JW; Orskov H; Alberti KG. (Sep 1991). Role of plasma non-esterified fatty acids during and after exercise. Clin Sci (Lond). 81:319-325.
  • Davis SN; Butler PC; Brown M; Beer S; Sobey W; Hanning I; Home PD; Hales CN; et alAlberti KG. (Sep 1991). The effects of human proinsulin on glucose turnover and intermediary metabolism. Metabolism. 40:953-961.
  • Gill GV; Alberti KG. (3 Aug 1991). Outcome of brittle diabetes. BMJ. 303:285-286.
  • Ramaiya KL; Swai AB; McLarty DG; Bhopal RS; Alberti KG. (3 Aug 1991). Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania. BMJ. 303:271-276.
  • Davis SN; Thompson CJ; Brown MD; Home PD; Alberti KG. (Aug 1991). A comparison of the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures. Diabetes Res Clin Pract. 13:107-117.
  • Crow YJ; Alberti KG; Parkin JM. (20 Jul 1991). Insulin dependent diabetes in childhood and material deprivation in northern England, 1977-86. BMJ. 303:158-160.
  • Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O. (Jul 1991). Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34:521-526.
  • Winocour PH; Kaluvya S; Brown L; Farrer M; Millar JP; Neil H; Alberti KG. (Jun 1991). The association of different measures of insulinaemia with vascular risk factors in healthy normoglycaemic normotensive non-obese men and women. Q J Med. 79:539-560.
  • Marsiaj HI; Catalano C; Sum CF; Home PD; Alberti KG. (May 1991). Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit. Diabetes Res Clin Pract. 12:129-136.
  • Marshall SM; Shearing PA; Shelley JH; Alberti KG. (May 1991). The effect of bromhexine on albumin excretion in insulin dependent diabetes. Diabete Metab. 17:332-336.
  • Swai AB; Kitange HM; McLarty DG; Kilima PM; Masuki G; Mtinangi BL; Alberti KG. (Apr 1991). No deterioration of oral glucose tolerance during pregnancy in rural Tanzania. Diabet Med. 8:254-257.
  • Stevenson RW; Steiner KE; Connolly CC; Fuchs H; Alberti KG; Williams PE; Cherrington AD. (Mar 1991). Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol. 260:E363-E370.
  • Houlston RS; Snowden C; Laker MF; Alberti KG; Humphries SE. (Mar 1991). Variation in the apolipoprotein B gene and development of type 2 diabetes mellitus. Dis Markers. 9:87-96.
  • Alberti KG. (Feb 1991). Diabetes and surgery. Anesthesiology. 74:209-211.
  • Broughton DL; James OW; Alberti KG; Taylor R. (Feb 1991). Peripheral and hepatic insulin sensitivity in healthy elderly human subjects. Eur J Clin Invest. 21:13-21.
  • Snowden C; Houlston RS; Arif MH; Laker MF; Humphries SE; Alberti KG. (31 Jan 1991). Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus. Clin Chim Acta. 196:49-57.
  • Alberti KG. (1991). A coordinated approach to treat chronic disorders. World Health Forum. 12:285-288.
  • Møller N; Blum WF; Mengel A; Hansen LB; Alberti KG; Schmitz O. (Jan 1991). Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia; evidence for increased muscle glucose uptake. Diabetologia. 34:17-20.
  • Gill GV; Alberti KG. (Jan 1991). Glucose-potassium-insulin infusion: correction. Br J Hosp Med. 45:18.
  • Ferner RE; Antsiferov ML; Kelman AW; Alberti KG; Rawlins MD. (1991). The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes. Eur J Clin Pharmacol. 40:163-168.
  • Taylor R; Lovelock L; Tunbridge WM; Alberti KG; Brackenridge RG; Stephenson P; Young E. (1 Dec 1990). Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ. 301:1243-1247.
  • Ramaiya KL; Kodali VR; Alberti KG. (Dec 1990). Epidemiology of diabetes in Asians of the Indian subcontinent. Diabetes Metab Rev. 6:125-146.
  • Mugusi F; Swai AB; Alberti KG; McLarty DG. (Dec 1990). Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle. 71:271-276.
  • Møller N; Jørgensen JO; Møller J; Orskov L; Pørksen N; Alberti KG; Schmitz O. (Dec 1990). Lack of effects of hyperglycemia on the disposal of 3-hydroxybutyrate in insulin-dependent diabetic patients. Acta Endocrinol (Copenh). 123:629-632.
  • Møller N; Jørgensen JO; Møller J; Bak JF; Pørksen N; Alberti KG; Schmitz O. (Dec 1990). Substrate metabolism during modest hyperinsulinemia in response to isolated hyperketonemia in insulin-dependent diabetic subjects. Metabolism. 39:1309-1313.
  • Kawo NG; Msengi AE; Swai AB; Chuwa LM; Alberti KG; McLarty DG; Orskov H. (3 Nov 1990). Hypoglycaemia and cerebral malaria. Lancet. 336:1128-1129.
  • Dowse GK; Qin H; Collins VR; Zimmet PZ; Alberti KG; Gareeboo H. (Nov 1990). Determinants of estimated insulin resistance and beta-cell function in Indian, Creole and Chinese Mauritians. The Mauritius NCD Study Group. Diabetes Res Clin Pract. 10:265-279.
  • Mugusi F; Swai AB; Turner SJ; Alberti KG; McLarty DG. (Nov 1990). Hypoadrenalism in patients with pulmonary tuberculosis in Tanzania: an undiagnosed complication?. Trans R Soc Trop Med Hyg. 84:849-851.
  • Ramaiya KL; Swai AB; McLarty DG; Alberti KG. (Nov 1990). Improvement in glucose tolerance after one year of follow-up in a Hindu community in Africa. Diabetes Res Clin Pract. 10:245-255.
  • Mogensen CE; Christensen CK; Pedersen MM; Alberti KG; Boye N; Christensen T; Christiansen JS; Flyvbjerg A; et alIngerslev J; Schmitz A. (Oct 1990). Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. J Diabet Complications. 4:159-165.
  • Ridley PD; Ratcliffe JM; Alberti KG; Elliott MJ. (Oct 1990). The metabolic consequences of a "washed" cardiopulmonary bypass pump-priming fluid in children undergoing cardiac operations. J Thorac Cardiovasc Surg. 100:528-537.
  • Catalano C; Goodship TH; Tapson JS; Venning MK; Taylor RM; Proud G; Tunbridge WM; Elliot RW; et alWard MK; Alberti KG. (15 Sep 1990). Renal replacement treatment for diabetic patients in Newcastle upon Tyne and the Northern region, 1964-88. BMJ. 301:535-540.
  • Yudkin JS; Alberti KG; McLarty DG; Swai AB. (1 Sep 1990). Impaired glucose tolerance. BMJ. 301:397-402.
  • Kawo NG; Msengi AE; Swai AB; Chuwa LM; Alberti KG; McLarty DG. (25 Aug 1990). Specificity of hypoglycaemia for cerebral malaria in children. Lancet. 336:454-457.
  • Finch CF; Zimmet PZ; Alberti KG. (Aug 1990). Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations?. Diabet Med. 7:603-610.
  • Beer SF; Heaton DA; Alberti KG; Pyke DA; Leslie RD. (Aug 1990). Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins. Diabetologia. 33:497-502.
  • Jones IR; Swai A; Taylor R; Miller M; Laker MF; Alberti KG. (Aug 1990). Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM. Diabetes Care. 13:855-863.
  • Walker M; Fulcher GR; Catalano C; Petranyi G; Orskov H; Alberti KG. (Aug 1990). Physiological levels of plasma non-esterified fatty acids impair forearm glucose uptake in normal man. Clin Sci (Lond). 79:167-174.
  • McLarty DG; Athaide I; Bottazzo GF; Swai AM; Alberti KG. (Jul 1990). Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. Diabetes Res Clin Pract. 9:219-224.
  • Yajnik CS; Shelgikar KM; Sahasrabudhe RA; Naik SS; Pai VR; Alberti KG; Hockaday TD; Katrak A; et alDandona P. (Jul 1990). The spectrum of pancreatic exocrine and endocrine (beta-cell) function in tropical calcific pancreatitis. Diabetologia. 33:417-421.
  • Cooper BG; Taylor R; Alberti KG; Gibson GJ. (May 1990). Lung function in patients with diabetes mellitus. Respir Med. 84:235-239.
  • Yajnik CS; Kanitkar SV; Shelgikar KM; Naik SS; Alberti KG; Hockaday D. (May 1990). Pancreatic C-peptide response to oral glucose in fibrocalculous pancreatic diabetes. Improvement after treatment. Diabetes Care. 13:525-527.
  • Møller N; Jørgensen JO; Alberti KG; Flyvbjerg A; Schmitz O. (Apr 1990). Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab. 70:1179-1186.
  • Goodship TH; Butler PC; Rodham D; Clayton B; Home PD; Alberti KG. (Apr 1990). Total-body potassium in insulin-dependent diabetes mellitus. Clin Sci (Lond). 78:377-381.
  • Swai AB; McLarty DG; Sherrif F; Chuwa LM; Maro E; Lukmanji Z; Kermali W; Makene W; et alAlberti KG. (Mar 1990). Diabetes and impaired glucose tolerance in an Asian community in Tanzania. Diabetes Res Clin Pract. 8:227-234.
  • Dowse GK; Gareeboo H; Zimmet PZ; Alberti KG; Tuomilehto J; Fareed D; Brissonnette LG; Finch CF. (Mar 1990). High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes. 39:390-396.
  • Kodali VR; Alberti KG. (Mar 1990). Re: The Eluru survey. Diabetes Res Clin Pract. 8:287-288.
  • Burrin JM; Alberti KG. (Mar 1990). What is blood glucose: can it be measured?. Diabet Med. 7:199-206.
  • Carr S; Mbanya JC; Thomas T; Keavey P; Taylor R; Alberti KG; Wilkinson R. (22 Feb 1990). Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. N Engl J Med. 322:500-505. DOI.
  • Agius L; Peak M; Alberti KG. (15 Feb 1990). Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes. Biochem J. 266:91-102.
  • Alberti KG; Jones IR; Laker MF; Swai AB; Taylor R. (1990). Effect of bezafibrate on metabolic profiles in non-insulin-dependent diabetes mellitus. J Cardiovasc Pharmacol. 16 Suppl 9:S21-S24.
  • Møller N; Jørgensen JO; Schmitz O; Møller J; Christiansen J; Alberti KG; Orskov H. (Jan 1990). Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol. 258:E86-E91.
  • Jørgensen JO; Møller N; Lauritzen T; Alberti KG; Orskov H; Christiansen JS. (Jan 1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab. 70:207-214.
  • Williams FM; Ferner RE; Graham M; Blain PG; Alberti KG; Rawlins MD. (1990). The metabolic effects of aspirin in fasting and fed subjects: relevance to the aetiology of Reye's syndrome. Eur J Clin Pharmacol. 38:519-521.
  • Walker M; Marshall SM; Alberti KG. (Dec 1989). Clinical aspects of diabetic ketoacidosis. Diabetes Metab Rev. 5:651-663.
  • Walsh TN; Fitzpatrick JM; Alderson D; Alberti KG; Farndon JR. (Dec 1989). Diurnal insulin and glucose profiles following transplantation of fresh and cryopreserved canine pancreatic islets. Br J Surg. 76:1287-1290.
  • Neil HA; Cassidy DM; Laker MF; Alberti KG. (Dec 1989). Within-clinic reagent strip lipid measurement. Diabet Med. 6:824-828.
  • Houlston RS; Snowden C; Green F; Alberti KG; Humphries SE. (Nov 1989). Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo CII. Hum Genet. 83:364-368.
  • Ferner RE; Alberti KG. (Nov 1989). Sulphonylureas in the treatment of non-insulin-dependent diabetes. Q J Med. 73:987-995.
  • Heaton A; Taylor R; Johnston DG; Ward MK; Wilkinson R; Alberti KG. (Oct 1989). Hepatic and peripheral insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis. Clin Sci (Lond). 77:383-388.
  • Bartlett K; Bhuiyan AK; Aynsley-Green A; Butler PC; Alberti KG. (Oct 1989). Human forearm arteriovenous differences of carnitine, short-chain acylcarnitine and long-chain acylcarnitine. Clin Sci (Lond). 77:413-416.
  • Tosh D; Alberti KG; Agius L. (15 Sep 1989). Clofibrate induces carnitine acyltransferases in periportal and perivenous zones of rat liver and does not disturb the acinar zonation of gluconeogenesis. Biochim Biophys Acta. 992:245-250.
  • Selam JL; Kashyap M; Alberti KG; Lozano J; Hanna M; Turner D; Jeandidier N; Chan E; et alCharles MA. (Sep 1989). Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus. Metabolism. 38:908-912.
  • Mbanya JC; Thomas TH; Taylor R; Alberti KG; Wilkinson R. (Sep 1989). Increased proximal tubular sodium reabsorption in hypertensive patients with type 2 diabetes. Diabet Med. 6:614-620.
  • Tunbridge FK; Newens A; Home PD; Davis SN; Murphy M; Burrin JM; Alberti KG; Jensen I. (Aug 1989). A comparison of human ultralente- and lente-based twice-daily injection regimens. Diabet Med. 6:496-501.
  • Dagogo-Jack S; Marshall SM; Kendall-Taylor P; Alberti KG. (Aug 1989). Urinary excretion of human epidermal growth factor in the various stages of diabetic nephropathy. Clin Endocrinol (Oxf). 31:167-173.
  • Cassidy DM; Pratt DA; Taylor R; Alberti KG; Laker MF. (30 Jun 1989). Capillary column gas chromatography-mass spectrometry for the determination of the fatty acid composition of human adipose tissue. J Chromatogr. 491:1-13.
  • Møller N; Beckwith R; Butler PC; Christensen NJ; Orskov H; Alberti KG. (Jun 1989). Metabolic and hormonal responses to exogenous hyperthermia in man. Clin Endocrinol (Oxf). 30:651-660.
  • Datta H; Alberti KG. (Jun 1989). The lung as a target organ for thyroxine. Horm Metab Res. 21:305-308. DOI.
  • Tosh D; Alberti KG; Agius L. (15 May 1989). Hypophysectomy does not alter the acinar zonation of gluconeogenesis or the mitochondrial redox state in rat liver. Biochem J. 260:183-187.
  • McLarty DG; Swai AB; Kitange HM; Masuki G; Mtinangi BL; Kilima PM; Makene WJ; Chuwa LM; et alAlberti KG. (22 Apr 1989). Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet. 1:871-875.
  • Betley S; Alberti KG; Agius L. (1 Mar 1989). Regulation of fatty acid and carbohydrate metabolism by insulin, growth hormone and tri-iodothyronine in hepatocyte cultures from normal and hypophysectomized rats. Biochem J. 258:547-552.
  • Davies RR; Turner SJ; Alberti KG; Johnston DG. (Mar 1989). Somatostatin analogues in diabetes mellitus. Diabet Med. 6:103-111.
  • Hawthorne GC; Bartlett K; Hetherington CS; Alberti KG. (Mar 1989). The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells. Diabetologia. 32:163-166.
  • Tunbridge FK; Newens A; Home PD; Davis SN; Murphy M; Burrin JM; Alberti KG; Jensen I. (Feb 1989). Double-blind crossover trial of isophane (NPH)- and lente-based insulin regimens. Diabetes Care. 12:115-119.
  • Møller N; Butler PC; Antsiferov MA; Alberti KG. (Feb 1989). Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia. 32:105-110.
  • Orskov L; Schmitz O; Jørgensen JO; Arnfred J; Abildgaard N; Christiansen JS; Alberti KG; Orskov H. (Feb 1989). Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique. J Clin Endocrinol Metab. 68:276-282.
  • Marshall SM; Alberti KG. (Jan 1989). Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med. 70:61-71.
  • Alberti KG. (Jan 1989). Diabetic emergencies. Br Med Bull. 45:242-263.
  • Thomas TH; Mbanya JC; Taylor R; Alberti KG; Wilkinson R. (Dec 1988). Hypertension and diabetes mellitus: erythrocyte electrolytes and the effect of captopril treatment. J Hum Hypertens. 2:229-234.
  • Ahren B; Corrigan CB; Alberti KG. (Dec 1988). Plasma insulin and C-peptide responses to oral glucose in newly diagnosed diabetics in north-western Tanzania. East Afr Med J. 65:847-851.
  • Arnfred J; Schmitz O; Hother-Nielsen O; Orskov C; Beck-Nielsen H; Hermansen K; Christiansen JS; Alberti KG; et alOrskov H. (Nov 1988). Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes. Diabet Med. 5:755-760.
  • Kruszynska YT; Petranyi G; Alberti KG. (Oct 1988). Decreased insulin sensitivity and muscle enzyme activity in elderly subjects. Eur J Clin Invest. 18:493-498.
  • Swai AB; Harrison K; Chuwa LM; Makene W; McLarty D; Alberti KG. (Oct 1988). Screening for diabetes: does measurement of serum fructosamine help?. Diabet Med. 5:648-652.
  • Hawthorne GC; Alberti KG. (Oct 1988). The effect of high glucose and high insulin concentrations on pentose phosphate shunt enzymes and malic enzyme in cultured human endothelial cells. Horm Metab Res. 20:645-647. DOI.
  • Jørgensen JO; Flyvbjerg A; Lauritzen T; Alberti KG; Orskov H; Christiansen JS. (Jul 1988). Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. J Clin Endocrinol Metab. 67:36-40.
  • Gerondaes P; Alberti KG; Agius L. (1 Jul 1988). Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine. Biochem J. 253:161-167.
  • Hermansen K; Schmitz O; Boye N; Christensen CK; Christiansen JS; Alberti KG; Orskov H; Mogensen CE. (Jul 1988). Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion. Metabolism. 37:640-644.
  • Alberti KG. (Jul 1988). If I had non-insulin dependent diabetes mellitus. Br J Clin Pract. 42:269-272.
  • Christiansen CL; Schurizek BA; Malling B; Knudsen L; Alberti KG; Hermansen K. (Jul 1988). Insulin treatment of the insulin-dependent diabetic patient undergoing minor surgery. Continuous intravenous infusion compared with subcutaneous administration. Anaesthesia. 43:533-537.
  • Gerondaes P; Alberti KG; Agius L. (1 Jul 1988). Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes. Biochem J. 253:169-173.
  • Mbanya JC; Thomas TH; Wilkinson R; Alberti KG; Taylor R. (2 Apr 1988). Hypertension and hyperinsulinaemia: a relation in diabetes but not essential hypertension. Lancet. 1:733-734.
  • Samad AH; Ty Willing TS; Alberti KG; Taylor R. (Apr 1988). Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo. Diabetes Care. 11:337-344.
  • Ho KY; Veldhuis JD; Johnson ML; Furlanetto R; Evans WS; Alberti KG; Thorner MO. (Apr 1988). Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 81:968-975. DOI.
  • Marshall SM; Taylor R; Home PD; Alberti KG. (Apr 1988). Intermediary metabolism, insulin sensitivity and insulin receptor status under comparable long-term therapy with insulin injections and continuous subcutaneous insulin infusion. Acta Endocrinol (Copenh). 117:417-427.
  • Alberti KG; Gries FA. (Apr 1988). Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med. 5:275-281.
  • Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG. (Apr 1988). Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition. Am J Gastroenterol. 83:393-397.
  • Ratcliffe JM; Wyse RK; Hunter S; Alberti KG; Elliott MJ. (Apr 1988). The role of the priming fluid in the metabolic response to cardiopulmonary bypass in children of less than 15 kg body weight undergoing open-heart surgery. Thorac Cardiovasc Surg. 36:65-74. DOI.
  • Harrison J; Hodson AW; Skillen AW; Stappenbeck R; Agius L; Alberti KG. (Mar 1988). Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment. J Clin Chem Clin Biochem. 26:141-146.
  • Ferner RE; Rawlins MD; Alberti KG. (Feb 1988). Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes. Q J Med. 66:137-146.
  • King H; Alberti KG; Keen H; Bennett PH. (30 Jan 1988). Diagnosis of diabetes mellitus: pitfalls in the glucose tolerance test. Br Med J (Clin Res Ed). 296:357.
  • Alberti KG; Davis SN; Monti L; Moller N; Piatti P; Heine R. (Dec 1987). Methods for assessing insulin sensitivity in man. Biochem Soc Trans. 15:1027-1028.
  • Marshall SM; Home PD; Taylor R; Alberti KG. (Nov 1987). Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions. Diabet Med. 4:521-525.
  • Massi Benedetti M; Home PD; Gill GV; Burrin JM; Noy GA; Alberti KG. (Nov 1987). Hormonal and metabolic responses in brittle diabetic patients during feedback intravenous insulin infusion. Diabetes Res Clin Pract. 3:307-317.
  • Burrin JM; Alberti KG. (Nov 1987). Measurement of circulating intermediary metabolites. Baillieres Clin Endocrinol Metab. 1:1037-1071.
  • Jørgensen JO; Flyvbjerg A; Dinesen J; Lund H; Alberti KG; Orskov H; Christiansen JS. (Nov 1987). Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study. Acta Endocrinol (Copenh). 116:381-386.
  • Agius L; Wright PD; Alberti KG. (Jul 1987). Carnitine acyltransferases and acyl-CoA hydrolases in human and rat liver. Clin Sci (Lond). 73:3-10.
  • Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE. (Jul 1987). Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII). J Diabet Complications. 1:81-86.
  • Gray CS; Taylor R; French JM; Alberti KG; Venables GS; James OF; Shaw DA; Cartlidge NE; et alBates D. (May 1987). The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke. Diabet Med. 4:237-240.
  • Hermansen K; Møller A; Christensen CK; Christiansen JS; Schmitz O; Orskov H; Alberti KG; Mogensen CE. (Mar 1987). Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study. Acta Endocrinol (Copenh). 114:433-439.
  • Kruszynska YT; Home PD; Alberti KG. (Mar 1987). Insulin insensitivity and skeletal muscle enzyme activities in response to overinsulinization in the rat. Metabolism. 36:281-285.
  • Kruszynska YT; Home PD; Alberti KG. (Feb 1987). Very low density lipoprotein metabolism after insulin over-treatment and during a euglycaemic clamp. Eur J Clin Invest. 17:23-28.
  • Kruszynska YT; Home PD; Hanning I; Alberti KG. (Jan 1987). Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia. 30:16-21.
  • Petranyi G; Pulman G; Alberti KG. (Jan 1987). Blood collection bottles for glycated haemoglobin measurement. Ann Clin Biochem. 24 ( Pt 1):113-114.
  • Broughton DL; Alberti KG; James OF; Taylor R. (1987). Peripheral tissue insulin sensitivity in healthy elderly subjects. Gerontology. 33:357-362.
  • Johnston DG; Davies RR; Alberti KG; Miller M; Turner SJ; Watson M; Orskov H. (22 Dec 1986). Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans. Am J Med. 81:88-93.
  • Davies RR; Miller M; Turner SJ; Watson M; McGill A; Orskov H; Alberti KG; Johnston DG. (Dec 1986). Effects of somatostatin analogue SMS 201-995 in non-insulin-dependent diabetes. Clin Endocrinol (Oxf). 25:739-747.
  • Piniewska DM; McCulloch AJ; Bramble MG; Taylor R; Record CO; Alberti KG. (Dec 1986). Glucose turnover in compensated hepatic cirrhosis. Horm Metab Res. 18:834-837. DOI.
  • Ratcliffe JM; Elliott MJ; Wyse RK; Hunter S; Alberti KG. (Dec 1986). The metabolic load of stored blood. Implications for major transfusions in infants. Arch Dis Child. 61:1208-1214.
  • Thomas DJ; Platt HS; Alberti KG. (Nov 1986). Insulin infusion (GIK) in the treatment of type 2 (non-insulin dependent) diabetes during the perioperative period. Br J Surg. 73:898-901.
  • Agius L; Chowdhury MH; Alberti KG. (1 Nov 1986). Regulation of ketogenesis, gluconeogenesis and the mitochondrial redox state by dexamethasone in hepatocyte monolayer cultures. Biochem J. 239:593-601.
  • Agius L; Chowdhury MH; Davis SN; Alberti KG. (Nov 1986). Regulation of ketogenesis, gluconeogenesis, and glycogen synthesis by insulin and proinsulin in rat hepatocyte monolayer cultures. Diabetes. 35:1286-1293.
  • Leslie RD; Volkmann HP; Poncher M; Hanning I; Orskov H; Alberti KG. (4 Oct 1986). Metabolic abnormalities in children of non-insulin dependent diabetics. Br Med J (Clin Res Ed). 293:840-842.
  • Johnston DG; Johnson GA; Alberti KG; Millward-Sadler GH; Mitchell J; Wright R. (Oct 1986). Hepatic regeneration and metabolism after partial hepatectomy in diabetic rats: effects of insulin therapy. Eur J Clin Invest. 16:384-390.
  • Johnston DG; Johnson GA; Alberti KG; Millward-Sadler GH; Mitchell J; Wright R. (Oct 1986). Hepatic regeneration and metabolism after partial hepatectomy in normal rats: effects of insulin therapy. Eur J Clin Invest. 16:376-383.
  • Kruszynska YT; Petranyi G; Home PD; Taylor R; Alberti KG. (Oct 1986). Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 29:699-675.
  • Marshall SM; Hackett A; Court S; Parkin M; Alberti KG. (Sep 1986). Albumin excretion in children and adolescents with insulin-dependent diabetes. Diabetes Res. 3:345-348.
  • Petranyi G; Petranyi M; Sharpe GR; Alberti KG. (Sep 1986). Prevention of excess glycosylation of haemoglobin in filter paper blood spots taken for glycosylated haemoglobin measurement. Ann Clin Biochem. 23 ( Pt 5):608-609.
  • Alberti KG. (Sep 1986). What's in a name?. Diabet Med. 3:468.
  • Pernet A; Johnston DG; Hammond V; Orskov H; Alberti KG. (Aug 1986). Interactions of stress hormones on lipid and carbohydrate metabolism in man with partial insulin deficiency. Eur J Clin Invest. 16:310-315.
  • Hawthorne GC; MacLellan JR; Mythen M; Alberti KG; Turner GA. (Aug 1986). Studies on glomerular basement membrane in experimental diabetes using lectin histochemistry in Wistar rats. Diabetologia. 29:495-499.
  • Vadgama P; Covington AK; Alberti KG. (Jul 1986). Amperometric enzyme electrode system for extracorporeal lactate monitoring based on lactate dehydrogenase. Analyst. 111:803-807.
  • Taylor R; Hetherington CS; Gill GV; Alberti KG. (Jul 1986). Changes in tissue insulin sensitivity in previously "brittle" diabetics. Horm Metab Res. 18:493. DOI.
  • Trinick TR; Laker MF; Johnston DG; Keir M; Buchanan KD; Alberti KG. (Jul 1986). Effect of guar on second-meal glucose tolerance in normal man. Clin Sci (Lond). 71:49-55.
  • Ferner RE; Alberti KG; Rawlins MD. (Jul 1986). Massive glibenclamide overdose without hypoglycaemia in a man with diabetes after partial pancreatectomy. Hum Toxicol. 5:283-284.
  • Burrin JM; Newton-Adair I; Alberti KG. (Jul 1986). Stability of filter paper blood spot glucose. Diabet Med. 3:346.
  • Ferner RE; Ashworth L; Tronier B; Alberti KG. (Jun 1986). Effects of short-term hyperglycemia on insulin secretion in normal humans. Am J Physiol. 250:E655-E661.
  • Davies RR; Miller M; Turner SJ; Goodship TH; Cook DB; Watson M; McGill A; Orskov H; et alAlberti KG; Johnston DG. (Jun 1986). Effects of somatostatin analogue SMS 201-995 in normal man. Clin Endocrinol (Oxf). 24:665-674.
  • Francis AJ; Hanning I; Alberti KG. (Jun 1986). Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia. Diabetes Res. 3:263-268.
  • Kruszynska YT; Home PD; Alberti KG. (Jun 1986). In vivo regulation of liver and skeletal muscle glycogen synthase activity by glucose and insulin. Diabetes. 35:662-667.
  • Abu-Bakare A; Taylor R; Gill GV; Alberti KG. (17 May 1986). Tropical or malnutrition-related diabetes: a real syndrome?. Lancet. 1:1135-1138.
  • Taylor R; Heaton A; Hetherington CS; Alberti KG. (May 1986). Adipocyte insulin binding and insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis. Metabolism. 35:430-435.
  • Christensen CK; Schmitz O; Pedersen EB; Alberti KG; Mogensen CE. (May 1986). Effect of 3-hydroxybutyrate infusion on urinary protein excretion in healthy man. Scand J Clin Lab Invest. 46:239-243.
  • Kruszynska YT; Home PD; Morley A; Alberti KG. (May 1986). Preservation of islet function and morphology after transplantation into high dose streptozotocin-diabetic rats. Diabetes Res. 3:175-181.
  • Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG. (May 1986). The metabolic response to insulin deprivation in idiopathic brittle diabetes. Diabetes Res. 3:193-198.
  • Taylor R; Johnston DG; Alberti KG. (Apr 1986). Glucose homoeostasis in chronic liver disease. Clin Sci (Lond). 70:317-320.
  • Thompson J; Husband DJ; Thai AC; Alberti KG. (Apr 1986). Metabolic changes in the non-insulin-dependent diabetic undergoing minor surgery: effect of glucose-insulin-potassium infusion. Br J Surg. 73:301-304.
  • Turnbull DM; Dick DJ; Wilson L; Sherratt HS; Alberti KG. (Apr 1986). Valproate causes metabolic disturbance in normal man. J Neurol Neurosurg Psychiatry. 49:405-410.
  • Whittaker J; Hammond VA; Taylor R; Alberti KG. (1 Mar 1986). Effects of monensin on insulin interactions with isolated hepatocytes. Evidence for inhibition of receptor recycling and insulin degradation. Biochem J. 234:463-468.
  • Petranyi G; Kyne DA; Alberti KG. (Mar 1986). Evaluation of four modern home blood glucose meters including two memory meters. Diabet Med. 3:187-190.
  • Kruszynska YT; Home PD; Agius L; Alberti KG. (Mar 1986). Hepatic glycogen metabolism and insulin receptor status after long-term peripheral insulin delivery in the islet-transplanted diabetic rat. Diabetes. 35:306-310.
  • Marshall SM; Alberti KG. (Mar 1986). Screening for early diabetic nephropathy. Ann Clin Biochem. 23 ( Pt 2):195-197.
  • Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG. (Mar 1986). The management of severe brittle diabetes with "Infusaid" implantable pumps. Diabetes Res. 3:135-137.
  • Alberti KG. (Mar 1986). World aspects of diabetes. Diabet Med. 3:103-105.
  • Heaton A; Ward MK; Johnston DG; Alberti KG; Kerr DN. (Jan 1986). Evaluation of glycerol as an osmotic agent for continuous ambulatory peritoneal dialysis in end-stage renal failure. Clin Sci (Lond). 70:23-29.
  • Husband DJ; Thai AC; Alberti KG. (Jan 1986). Management of diabetes during surgery with glucose-insulin-potassium infusion. Diabet Med. 3:69-74.
  • Ferner RE; Alberti KG. (Jan 1986). Why is there still disagreement over insulin secretion in non-insulin-dependent diabetes?. Diabet Med. 3:13-17.
  • Krarup T; Madsbad S; Regeur L; Alberti KG; Faber OK; Kurtz A. (Dec 1985). The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics. Diabete Metab. 11:364-367.
  • Agius L; Alberti KG. (4 Nov 1985). Regulation of flux through pyruvate dehydrogenase and pyruvate carboxylase in rat hepatocytes. Effects of fatty acids and glucagon. Eur J Biochem. 152:699-707.
  • Battersby CM; Alberti KG; Agius L. (1 Nov 1985). Conversion of pyruvate into ketone bodies in rat hepatocyte suspensions. Biochem J. 231:565-569.
  • Hanning I; Home PD; Alberti KG. (Nov 1985). Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies. Diabetologia. 28:831-835.
  • Davies RR; Turner SJ; Cook D; Alberti KG; Johnston DG. (Nov 1985). The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44. Clin Endocrinol (Oxf). 23:521-525.
  • Barnes AJ; Kohner EM; Johnston DG; Alberti KG. (12 Oct 1985). Insulin deficiency, growth hormone, and retinopathy. Lancet. 2:841.
  • Zeuzem S; Taylor R; Agius L; Schoeffling K; Albisser AM; Alberti KG. (Oct 1985). Biological effects of sulphated insulin in adipocytes and hepatocytes. Mol Cell Biochem. 68:161-168.
  • Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG. (Oct 1985). Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients. Diabetologia. 28:728-733.
  • Heaton A; Johnston DG; Haigh JW; Ward MK; Alberti KG; Kerr DN. (Oct 1985). Twenty-four hour hormonal and metabolic profiles in uraemic patients before and during treatment with continuous ambulatory peritoneal dialysis. Clin Sci (Lond). 69:449-457.
  • Gill GV; Walford S; Alberti KG. (Aug 1985). Brittle diabetes--present concepts. Diabetologia. 28:579-589.
  • Home PD; Alberti KG; Rodger NW; Burrin JM. (Aug 1985). Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The Central Biochemistry Laboratory in the Multicenter Kroc Study. Problems and proposals. Diabetes. 34 Suppl 3:17-21.
  • Agius L; Pillay D; Alberti KG; Sherratt HS. (1 Aug 1985). Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes. Biochem Pharmacol. 34:2651-2654.
  • McKnight CK; Elliott MJ; Pearson DT; Holden MP; Alberti KG. (Jul 1985). The effects of four different crystalloid bypass pump-priming fluids upon the metabolic response to cardiac operation. J Thorac Cardiovasc Surg. 90:97-111.
  • Barnes AJ; Kohner EM; Johnston DG; Alberti KG. (29 Jun 1985). Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated circulating growth hormone. Lancet. 1:1465-1468.
  • Kruszynska YT; Home PD; Alberti KG. (Jun 1985). Comparison of portal and peripheral insulin delivery on lipid metabolism in streptozocin-diabetic rats. Diabetes. 34:611-616.
  • McKnight CK; Elliott M; Pearson DT; Alberti KG; Holden MP. (Jun 1985). Continuous monitoring of blood glucose concentration during open-heart surgery. Br J Anaesth. 57:595-601.
  • Christiansen JS; Kastrup KW; Alberti KG; Petersen KE; Christiansen C; Orskov H. (Jun 1985). Higher plasma somatomedin A (biological) and C (immunological) levels with sc than with im growth hormone replacement therapy. Acta Endocrinol (Copenh). 109:169-172.
  • Francis AJ; Hanning I; Alberti KG. (Jun 1985). The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins. Diabetologia. 28:330-334.
  • Heine RJ; Home PD; Poncher M; Orskov H; Hammond V; McCulloch AJ; Hanning I; Alberti KG. (May 1985). A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance. Diabetes Res. 2:113-120.
  • Schmitz O; Alberti KG; Christensen NJ; Hasling C; Hjøllund E; Beck-Nielsen H; Orskov H. (May 1985). Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism. 34:465-473.
  • Taylor R; McCulloch AJ; Zeuzem S; Gray P; Clark F; Alberti KG. (May 1985). Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Acta Endocrinol (Copenh). 109:96-103.
  • Husband DJ; Alberti KG; Julian DG. (May 1985). Methods for the control of diabetes after acute myocardial infarction. Diabetes Care. 8:261-267.
  • Agius L; Battersby C; Alberti KG. (May 1985). Monolayer culture of parenchymal rat hepatocytes on collagen-coated microcarriers. A hepatocyte system for short- and long-term metabolic studies. In Vitro Cell Dev Biol. 21:254-259.
  • Johnston DG; Haigh J; Prescott RW; Heaton A; Kendall-Taylor P; Baylis P; Alberti KG; Rowe R; et alFriesen H; Cook D. (May 1985). Prolactin secretion and biological activity in females with galactorrhoea and normal circulating prolactin concentrations at rest. Clin Endocrinol (Oxf). 22:661-678.
  • Steiner KE; Fuchs H; Williams PE; Stevenson RW; Cherrington AD; Alberti KG. (May 1985). Regulation of ketogenesis by epinephrine and norepinephrine in the overnight-fasted, conscious dog. Diabetes. 34:425-432.
  • Francis AJ; Hanning I; Alberti KG. (May 1985). The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection. Diabet Med. 2:177-180.
  • Spruce BA; McCulloch AJ; Burd J; Orskov H; Heaton A; Baylis PH; Alberti KG. (Apr 1985). The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf). 22:463-468.
  • Francis AJ; Brown M; Alberti KG. (23 Mar 1985). Errors in blood glucose determination. Lancet. 1:704.
  • Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H. (Mar 1985). Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy. Diabetes Res. 2:57-63.
  • Bell PM; Henry RW; Buchanan KD; Alberti KG. (Mar 1985). Cimetidine fails to suppress the rise in plasma secretin during fasting. Regul Pept. 10:127-131.
  • Kruszynska YT; Home PD; Alberti KG. (Mar 1985). Comparison of portal and peripheral insulin delivery on carbohydrate metabolism in streptozotocin-diabetic rats. Diabetologia. 28:167-171.
  • Francis AJ; Home PD; Walford S; Alberti KG; Mann N; Reeves WG. (Mar 1985). Prevalence of morning hyperglycaemia: determinants of fasting blood glucose concentrations in insulin-treated diabetics. Diabet Med. 2:89-94.
  • Home PD; Gill GV; Husband D; Kruszynska YT; Marshall S; Alberti KG. (1985). Alternative routes and methods of insulin delivery. Neth J Med. 28 Suppl 1:32-36.
  • Falholt K; Alberti KG; Heding LG. (Jan 1985). Aorta and muscle metabolism in pigs with peripheral hyperinsulinaemia. Diabetologia. 28:32-37.
  • Walford S; Alberti KG. (1985). Biochemical self-monitoring: promise, practice and problems. Contemp Issues Clin Biochem. 2:200-213.
  • Taylor R; Heine RJ; Collins J; James OF; Alberti KG. (Jan 1985). Insulin action in cirrhosis. Hepatology. 5:64-71.
  • Turnbull DM; Bartlett K; Stevens DL; Alberti KG; Gibson GJ; Johnson MA; McCulloch AJ; Sherratt HS. (8 Nov 1984). Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med. 311:1232-1236. DOI.
  • Capaldo B; Home PD; Massi-Benedetti M; Worth R; Cook DB; Heaton A; Alberti KG. (Nov 1984). The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetes. Diabetes Res. 1:187-193.
  • Pulman G; Laker MF; Fail B; Alberti KG. (13 Oct 1984). Haemoglobinopathies and glycosylated haemoglobin estimation. Br Med J (Clin Res Ed). 289:1001-1002.
  • Taylor R; Husband DJ; Marshall SM; Tunbridge WM; Alberti KG. (Oct 1984). Adipocyte insulin binding and insulin sensitivity in 'brittle' diabetes. Diabetologia. 27:441-446.
  • McCulloch AJ; Steele NR; Kendall-Taylor P; Baylis PH; Alberti KG. (Oct 1984). Enhanced gluconeogenic capacity from glycerol in hyperthyroid man: evidence in favour of a beta-adrenergic mechanism. Clin Endocrinol (Oxf). 21:399-407.
  • Bell PM; Henry RW; Buchanan KD; Alberti KG. (Sep 1984). The effect of starvation on the gastro-entero-pancreatic hormonal and metabolic responses to exercise. (GEP hormones in starvation and exercise). Diabete Metab. 10:194-198.
  • Zeuzem S; Taylor R; Agius L; Albisser AM; Alberti KG. (Aug 1984). Differential binding of sulphated insulin to adipocytes and hepatocytes. Diabetologia. 27:184-188.
  • Cherrington AD; Fuchs H; Stevenson RW; Williams PE; Alberti KG; Steiner KE. (Aug 1984). Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs. Am J Physiol. 247:E137-E144.
  • Alderson D; Farndon JR; Alberti KG; Johnston ID. (Aug 1984). Islet autotransplantation in the pancreatectomized dog: effect of time on graft function. World J Surg. 8:590-597.
  • Bahnsen M; Burrin JM; Johnston DG; Pernet A; Walker M; Alberti KG. (Aug 1984). Mechanisms of catecholamine effects on ketogenesis. Am J Physiol. 247:E173-E180.
  • Husband DJ; Marshall SM; Walford S; Hanning I; Wright PD; Alberti KG. (Jul 1984). Continuous intraperitoneal insulin infusion in the management of severely brittle diabetes--a metabolic and clinical comparison with intravenous infusion. Diabet Med. 1:99-104.
  • Thomas DJ; Platt HS; Alberti KG. (Jul 1984). Insulin-dependent diabetes during the peri-operative period. An assessment of continuous glucose-insulin-potassium infusion, and traditional treatment. Anaesthesia. 39:629-637.
  • Heaton A; Ward MK; Johnston DG; Nicholson DV; Alberti KG; Kerr DN. (Jul 1984). Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD). Clin Sci (Lond). 67:121-130.
  • Ponchner M; Heine RJ; Pernet A; Hanning I; Francis AJ; Cook D; Orskov H; Alberti KG. (Jun 1984). A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping. Diabetologia. 26:420-425.
  • Heine RJ; Ponchner M; Hanning I; Home PD; Brown M; Williams D; Alberti KG. (Jun 1984). A comparison of the effects of semisynthetic human insulin and porcine insulin on transmembrane ion shifts and glucose metabolism during euglycaemic clamping. Acta Endocrinol (Copenh). 106:241-247.
  • Taylor R; Alberti KG. (May 1984). Hyperproinsulinaemia in cirrhosis. Diabetologia. 26:392.
  • Thai AC; Husband DJ; Gill GV; Alberti KG. (May 1984). Management of diabetes during surgery. A retrospective study of 112 cases. Diabete Metab. 10:65-70.
  • Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG. (May 1984). Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin. Diabete Metab. 10:98-105.
  • Elliott MJ; Gill GV; Home PD; Noy GA; Holden MP; Alberti KG. (Apr 1984). A comparison of two regimens for the management of diabetes during open-heart surgery. Anesthesiology. 60:364-368.
  • Viberti GC; Home PD; Bilous RW; Alberti KG; Dalton N; Keen H; Pickup JC. (Apr 1984). Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy. Acta Endocrinol (Copenh). 105:515-520.
  • Ponchner M; Taylor R; Heine R; Alberti KG. (Apr 1984). The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics. Horm Metab Res. 16:208. DOI.
  • Walford S; Home PD; Alberti KG. (Mar 1984). A laboratory trial of two new blood-glucose reflectance meters featuring automatic external calibration. Ann Clin Biochem. 21 ( Pt 2):116-119.
  • Schmitz O; Alberti KG; Orskov H. (Mar 1984). Insulin resistance in uraemic insulin-dependent diabetics. Effect of dialysis therapy as assessed by the artificial endocrine pancreas. Acta Endocrinol (Copenh). 105:371-378.
  • Conlon JM; McCulloch AJ; Ward M; Goodship T; Alberti KG. (Mar 1984). Unimpaired clearance of somatostatin-14 in chronic renal failure. Horm Metab Res. 16:151-152. DOI.
  • Bartlett K; Ghneim HK; Stirk JH; Dale G; Alberti KG. (1984). Pyruvate carboxylase deficiency. J Inherit Metab Dis. 7 Suppl 1:74-78.
  • Rowan RM; Laker MF; Alberti KG. (Jan 1984). The implications of assaying external quality control sera under 'special conditions'. Ann Clin Biochem. 21 ( Pt 1):64-68.
  • Pernet A; Hammond VA; Blesa-Malpica G; Burrin J; Orskov H; Alberti KG; Johnston DG. (1984). The metabolic effects of dopamine in man. Eur J Clin Pharmacol. 26:23-28.
  • Worth R; Ashworth L; Home PD; Gerrard J; Lind T; Anderson J; Alberti KG. (Dec 1983). Glycosylated haemoglobin in cord blood following normal and diabetic pregnancies. Diabetologia. 25:482-485.
  • Agius L; Wilding C; Alberti KG. (15 Nov 1983). Metabolic effects of bacitracin in isolated rat hepatocytes. Biochem J. 216:369-375.
  • Marshall SM; Alberti KG. (Nov 1983). Assessment of a new visual test strip for blood glucose monitoring. Diabetes Care. 6:543-547.
  • Heaton A; Johnston DG; Burrin JM; Orskov H; Ward MK; Alberti KG; Kerr DN. (Nov 1983). Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle. Clin Sci (Lond). 65:539-545.
  • Andrews WJ; Henry RW; Alam MJ; Alberti KG; Buchanan KD. (Oct 1983). Failure of fasting to influence the GIP response to oral glucose in non-obese human subjects. Diabetologia. 25:372-374.
  • Stewart A; Johnston DG; Alberti KG; Nattrass M; Wright R. (Oct 1983). Hormone and metabolite profiles in alcoholic liver disease. Eur J Clin Invest. 13:397-403.
  • Schmitz O; Rømer FK; Alberti KG; Hreidarsson AB; Orskov H. (Sep 1983). Angiotensin-converting enzyme in diabetes mellitus dependence on metabolic aberration. Diabete Metab. 9:179-182.
  • Johnston DG; Blesa-Malpica G; Burrin JM; Waugh C; Cook D; Orskov H; Alberti KG. (Sep 1983). Dopamine blockade inhibits starvation ketosis in man. Clin Endocrinol (Oxf). 19:389-396.
  • Heine RJ; Hanning I; Morgan L; Alberti KG. (Sep 1983). The oral glucose tolerance test (OGTT): effect of rate of ingestion of carbohydrate and different carbohydrate preparations. Diabetes Care. 6:441-445.
  • Conlon JM; McCulloch AJ; Alberti KG. (Aug 1983). Circulating somatostatin concentrations in healthy and non-insulin-dependent (type II) diabetic subjects. Diabetes. 32:723-729.
  • Stevenson RW; Orskov H; Parsons JA; Alberti KG. (Aug 1983). Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs. Am J Physiol. 245:E200-E208.
  • Husband DJ; Alberti KG; Julian DG. (23 Jul 1983). "Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes?. Lancet. 2:179-181.
  • Johnston DG; Alberti KG. (Jul 1983). Acid-base balance in metabolic acidoses. Clin Endocrinol Metab. 12:267-285.
  • McCulloch AJ; Johnston DG; Baylis PH; Kendall-Taylor P; Clark F; Young ET; Alberti KG. (Jul 1983). Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. Clin Endocrinol (Oxf). 19:67-76.
  • Vadgama P; Alberti KG. (15 Jun 1983). The effect of a gastric mucus barrier on the dynamic response of a pH electrode. Experientia. 39:573-576.
  • Sheppard MC; Burrin J; Alberti KG; Nattrass M. (May 1983). The effect of diet on intermediary metabolite concentrations in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 24:333-335.
  • Francis AJ; Home PD; Hanning I; Alberti KG; Tunbridge WM. (9 Apr 1983). Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast. Br Med J (Clin Res Ed). 286:1173-1176.
  • McCulloch AJ; Home PD; Heine R; Ponchner M; Hanning I; Johnston DG; Clark F; Alberti KG. (Apr 1983). Insulin sensitivity in hyperthyroidism: measurement by the glucose clamp technique. Clin Endocrinol (Oxf). 18:327-333.
  • Home PD; Hanning I; Capaldo B; Alberti KG. (Mar 1983). Bioavailability of highly purified bovine ultralente insulin. Diabetes Care. 6:210.
  • Home PD; Shepherd GA; Noy G; Massi-Benedetti M; Hanning I; Burrin JM; Alberti KG. (Mar 1983). Comparison of the activity and pharmacokinetics of porcine insulin and human insulin (Novo) as assessed by the glucose clamp technique in normal and diabetic man. Diabetes Care. 6 Suppl 1:23-28.
  • Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Burrin J; Alberti KG. (Mar 1983). Metabolic studies in chlorpropamide-alcohol flush positive and negative Type 2 (non-insulin dependent) diabetic patients with and without retinopathy. Diabetologia. 24:213-215.
  • Stevenson RW; Parsons JA; Alberti KG. (Feb 1983). Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs. Am J Physiol. 244:E190-E195.
  • Stubbs WA; Delitala G; Besser GM; Edwards CR; Labrooy S; Taylor R; Misiewicz JJ; Alberti KG. (Feb 1983). The endocrine and metabolic effects of cimetidine. Clin Endocrinol (Oxf). 18:167-178.
  • McCulloch AJ; Nosadini R; Pernet A; Piniewska M; Cook DB; Clark F; Johnston DG; Alberti KG. (Jan 1983). Glucose turnover and indices of recycling in thyrotoxicosis and primary thyroid failure. Clin Sci (Lond). 64:41-47.
  • Vadgama P; Alberti KG. (1983). The possible role of bicarbonate in mucosal protection and peptic ulceration. Digestion. 27:203-213.
  • Home PD; Massi-Benedetti M; Gill GV; Capaldo B; Shepherd GA; Alberti KG. (Nov 1982). Impaired subcutaneous absorption of insulin in 'brittle' diabetics. Acta Endocrinol (Copenh). 101:414-420.
  • Home PD; Alberti KG. (Nov 1982). The new insulins. Their characteristics and clinical indications. Drugs. 24:401-413.
  • Nosadini R; Mcculloch A; Del Prato S; Avogaro A; Alberti KG. (Nov 1982). The relationship between alanine and ketone body in vivo. Metabolism. 31:1175-1178.
  • Worth R; Home PD; Johnston DG; Anderson J; Ashworth L; Burrin JM; Appleton D; Binder C; et alAlberti KG. (30 Oct 1982). Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed). 285:1233-1240.
  • Conlon JM; Bridgeman M; Alberti KG. (15 Sep 1982). The nature of big plasma somatostatin: implications for the measurement of somatostatin-like immunoreactivity in human plasma. Anal Biochem. 125:243-252.
  • Home PD; Capaldo B; Burrin JM; Worth R; Alberti KG. (Sep 1982). A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care. 5:466-471.
  • Leslie RD; Eff C; Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Alberti KG. (Sep 1982). Opiate receptors and the metabolic response to intravenous glucose. Diabete Metab. 8:235-239.
  • Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H. (Sep 1982). The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas). Diabetologia. 23:220-228.
  • Johnston DG; Alberti KG. (Jul 1982). Hormonal control of ketone body metabolism in the normal and diabetic state. Clin Endocrinol Metab. 11:329-361.
  • Home PD; Alberti KG. (Jul 1982). Human insulin. Clin Endocrinol Metab. 11:453-483.
  • Cobelli C; Nosadini R; Toffolo G; McCulloch A; Avogaro A; Tiengo A; Alberti KG. (Jul 1982). Model of the kinetics of ketone bodies in humans. Am J Physiol. 243:R7-17.
  • Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; et alHome PD. (Jun 1982). A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects. Diabete Metab. 8:155-158.
  • McCulloch AJ; Johnston DG; Burrin JM; Hodson AW; Clark F; Waugh C; Alberti KG. (Jun 1982). Diurnal metabolic profiles in hyperthyroidism. Eur J Clin Invest. 12:269-276.
  • Whittaker J; Cuthbert C; Hammond VA; Alberti KG. (Jun 1982). The effects of metabolic acidosis in vivo on insulin binding to isolated rat adipocytes. Metabolism. 31:553-557.
  • Madsbad S; Faber OK; Kurtz A; Krarup T; Regeur L; Tronier B; Orskov H; Binder C; et alAlberti KG. (Jun 1982). The significance of the portal insulin secretion in insulin dependent patients with residual beta-cell function: a safeguard against hormonal and metabolic derangement. Clin Endocrinol (Oxf). 16:605-613.
  • Schmitz O; Hansen AP; Hansen HE; Orskov H; Alberti KG. (May 1982). Acetate suppresses growth hormone secretion in uremic patients: hemodialysis and acetate infusion experiments. Artif Organs. 6:132-135.
  • Alberti KG; Gill GV; Elliott MJ. (May 1982). Insulin delivery during surgery in the diabetic patient. Diabetes Care. 5 Suppl 1:65-77.
  • Ploybutr S; Burrin JM; Alberti KG. (May 1982). Rapid in vitro glycosylation of hemoglobin: a hazard of column-chromatographic but not colorimetric techniques. Clin Chem. 28:1233-1234.
  • Orskov H; Hansen AP; Hansen HE; Alberti KG; Noy GA; Nosadini R. (Apr 1982). Acetate: inhibitor of growth hormone hypersecretion in diabetic and non-diabetic uraemic subjects. Acta Endocrinol (Copenh). 99:551-558.
  • Johnston DG; Alberti KG; Wright R; Blain PG. (Apr 1982). Glycerol clearance in alcoholic liver disease. Gut. 23:257-264.
  • Johnston DG; Gill A; Orskov H; Batstone GF; Alberti KG. (Apr 1982). Metabolic effects of cortisol in man--studies with somatostatin. Metabolism. 31:312-317.
  • Gill A; Johnston DG; Orskov H; Batstone GF; Alberti KG. (Apr 1982). Metabolic interactions of glucagon and cortisol in man--studies with somatostatin. Metabolism. 31:305-311.
  • Vadgama P; Mitchison J; Covington AK; Alberti KG. (12 Mar 1982). Interferent ion effects on the Orion SS-20 Calcium Ion Analyser. Clin Chim Acta. 119:249-256.
  • Pickup JC; Viberti GC; Bilous RW; Keen H; Alberti KG; Home PD; Binder C. (Mar 1982). Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia. 22:175-179.
  • Pernet A; Johnston DG; Burrin JM; Orskov H; Alberti KG. (Mar 1982). Transient triiodothyronine deficiency. Absence of effect on basal or adrenaline-stimulated carbohydrate and lipid metabolism in man. Diabete Metab. 8:41-46.
  • Home PD; Massi-Benedetti M; Shepherd GA; Hanning I; Alberti KG; Owens DR. (Jan 1982). A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique. Diabetologia. 22:41-45.
  • Johnston DG; Alberti KG; Binder C; Faber OK; Wright R; Orskov H. (Jan 1982). Hormonal and metabolic changes in hepatic cirrhosis. Horm Metab Res. 14:34-39. DOI.
  • Stubbs WA; Kelly DM; Morgan I; Alberti KG. (Jan 1982). Insulin clearance by perfused rat lung. Horm Metab Res. 14:8-9. DOI.
  • Johnston DG; Pernet A; McCulloch A; Blesa-Malpica G; Burrin JM; Alberti KG. (1982). Some hormonal influences on glucose and ketone body metabolism in normal human subjects. Ciba Found Symp. 87:168-191.
  • Alberti KG; Cuthbert C. (1982). The hydrogen ion in normal metabolism: a review. Ciba Found Symp. 87:1-19.
  • Foster KJ; Alberti KG; Binder C; Holdstock G; Karran SJ; Smith CL; Talbot S; Turnell DC. (Jan 1982). The metabolic effects of moderately severe upper gastrointestinal haemorrhage in man. Postgrad Med J. 58:25-29.
  • Whittaker J; Hammond VA; Alberti KG. (15 Dec 1981). Effects of colchicine on insulin binding to isolated rat hepatocytes. Biochem Biophys Res Commun. 103:1100-1106.
  • McCulloch AJ; Johnston DG; Burrin JM; Hodson AW; Clark F; Waugh C; Orskov H; Alberti KG. (Dec 1981). Diurnal hormone-metabolite profiles in hypothyroidism. Clin Endocrinol (Oxf). 15:607-619.
  • Whittaker J; Cuthbert C; Hammond V; Alberti KG. (Dec 1981). Impaired insulin binding to isolated adipocytes in experimental diabetic ketoacidosis. Diabetologia. 21:563-568.
  • Hanson RD; Gray RM; Alberti KG. (Nov 1981). Liver metabolites in resting and exercising rats at 1 and 4 bar. J Appl Physiol. 51:1326-1330.
  • Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG. (Nov 1981). Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes. 30:951-954.
  • Andrews WJ; Henry RW; Alberti KG; Buchanan KD. (Nov 1981). The gastro-entero-pancreatic hormone response to fasting in obesity. Diabetologia. 21:440-445.
  • Conlon JM; Whittaker J; Hammond V; Alberti KG. (12 Oct 1981). Metabolism of somatostatin and its analogues by the liver. Biochim Biophys Acta. 677:234-242.
  • Twentyman OP; Disley A; Gribbin HR; Alberti KG; Tattersfield AE. (Oct 1981). Effect of beta-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol. 51:788-793.
  • Schmitz O; Alberti KG; Hreidarsson AB; Laurberg P; Weeke J; Orskov H. (Oct 1981). Suppression of the night increase in serum TSH during development of ketosis in diabetic patients. J Endocrinol Invest. 4:403-407.
  • Stevenson RW; Parsons JA; Alberti KG. (Aug 1981). Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs. Metabolism. 30:745-752.
  • Nosadini R; Noy G; Kurtz AB; Alberti KG. (Aug 1981). Differential response to infusions of highly purified and conventional bovine and porcine insulins. Diabetes. 30:650-655.
  • Owens DR; Jones MK; Hayes TM; Heding LG; Alberti KG; Home PD; Burrin JM. (18 Jul 1981). Comparative study of subcutaneous, intramuscular, and intravenous administration of human insulin. Lancet. 2:118-122.
  • Burrin JM; Worth R; Law S; Alberti KG. (Jul 1981). Simple filter paper method for home monitoring of blood glucose, lactate, and 3-hydroxybutyrate. Ann Clin Biochem. 18:243-247.
  • Nosadini R; Alberti KG; Johnston DG; Del Prato S; Marescotti C; Duner E. (Jun 1981). The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. Metabolism. 30:563-567.
  • Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Burrin J; Alberti KG. (23 May 1981). Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. Br Med J (Clin Res Ed). 282:1656-1658.
  • Worth RC; Harrison K; Anderson J; Johnston DG; Alberti KG. (May 1981). A comparison study of blood glucose test strips. Diabetes Care. 4:407-411.
  • Harvey JE; Baldwin CJ; Wood PJ; Alberti KG; Tattersfield AE. (May 1981). Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond). 60:579-585.
  • Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C. (May 1981). Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Metabolism. 30:439-442.
  • Blesa-Malpica G; Johnston DG; Burrin JM; Orskov H; Heath AB; Alberti KG. (May 1981). Dopaminergic control of ketogenesis in fasting. Clin Endocrinol (Oxf). 14:479-484.
  • Taylor R; Home PD; Alberti KG. (May 1981). Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection. Diabetes Care. 4:377-379.
  • Owens DR; Jones MK; Hayes TM; Heding LG; Alberti KG; Home PD; Burrin JM; Newcombe RG. (18 Apr 1981). Human insulin: study of safety and efficacy in man. Br Med J (Clin Res Ed). 282:1264-1266.
  • Madsbad S; Faber OK; Binder C; Alberti KG; Lloyd B. (Apr 1981). Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function. Acta Diabetol Lat. 18:115-121.
  • Massi-Benedetti M; Burrin JM; Capaldo B; Alberti KG. (Mar 1981). A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects. Diabetes Care. 4:163-167.
  • Massi-Benedetti M; Noy G; Johnston ID; Worth R; Alberti KG. (Mar 1981). Glucose controlled insulin infusion system (Biostator) application during surgery for a presumed pancreatic microinsulinoma. Diabete Metab. 7:41-44.
  • Gill GV; Sherif IH; Alberti KG. (Mar 1981). Management of diabetes during open heart surgery. Br J Surg. 68:171-172.
  • Alberti KG; Johnston DG; Burrin J; Blesa-Malpica G; McCulloch A; Nosadini R; Walker M. (Feb 1981). Ketogenesis: regulatory factors in vivo. Biochem Soc Trans. 9:8-9.
  • Metcalfe P; Johnston DG; Nosadini R; Orksov H; Alberti KG. (Feb 1981). Metabolic effects of acute and prolonged growth hormone excess in normal and insulin-deficient man. Diabetologia. 20:123-128.
  • Whittaker J; Hammond VA; Alberti KG. (Feb 1981). The effects of colchicine on insulin binding to isolated rat hepatocytes. Biochem Soc Trans. 9:88-89.
  • Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H. (Feb 1981). The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes. Diabetologia. 20:113-117.
  • Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG. (31 Jan 1981). Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J (Clin Res Ed). 282:347-350.
  • deSilva NE; Tunbridge WM; Alberti KG. (17 Jan 1981). Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin-dependent diabetes. Lancet. 1:128-131.
  • Home PD; Alberti KG; Worth R. (10 Jan 1981). Are reflectance meters necessary for home blood glucose monitoring?. Br Med J (Clin Res Ed). 282:149.
  • Alberti KG; Johnston DG; Piniewska-Hulas M; Whittaker J. (1981). Disturbances of metabolic homeostasis is liver disease. Acta Med Port. 35-47.
  • Johnston DG; Alberti KG. (Nov 1980). Diabetic emergencies: practical aspects of the management of diabetic ketoacidosis and diabetes during surgery. Clin Endocrinol Metab. 9:437-460.
  • Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF. (Oct 1980). Hormonal and metabolic rhythms in Cushing's syndrome. Metabolism. 29:1046-1052.
  • Turnbull DM; Johnston DG; Alberti KG; Hall R. (Oct 1980). Hormonal and metabolic studies in a patient with a pheochromocytoma. J Clin Endocrinol Metab. 51:930-933.
  • Johnston DG; Alberti KG; Nattrass M; Burrin JM; Blesa-Malpica G; Hall K; Hall R. (Oct 1980). Hyperinsulinaemia in hyperprolactinaemic women. Clin Endocrinol (Oxf). 13:361-368.
  • Worth R; Anderson J; Taylor R; Alberti KG. (13 Sep 1980). Jet injection of insulin: comparison with conventional injection by syringe and needle. Br Med J. 281:713-714.
  • Burrin JM; Worth R; Ashworth LA; Currie S; Alberti KG. (8 Sep 1980). Automated colorimetric estimation of glycosylated haemoglobins. Clin Chim Acta. 106:45-50.
  • Holgate ST; Stubbs WA; Wood PJ; McCaughey ES; Alberti KG; Tattersfield AE. (Sep 1980). Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond). 59:155-161.
  • Leatherdale BA; Chase RA; Rogers J; Alberti KG; Davies P; Record CO. (Sep 1980). Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance. Clin Sci (Lond). 59:191-198.
  • Alberti KG. (Sep 1980). The World Health Organisation and diabetes. Diabetologia. 19:169-173.
  • Nosadini R; Datta H; Hodson A; Alberti KG. (15 Aug 1980). A possible mechanism for the anti-ketogenic action of alanine in the rat. Biochem J. 190:323-332.
  • Alberti KG. (26 Jul 1980). Impaired glucose tolerance. Lancet. 2:211.
  • Worth RC; Ashworth LA; Burrin JM; Johnston DG; Skillen AW; Anderson J; Alberti KG. (1 Jul 1980). Column assay of haemoglobin A1: critical effect of temperature. Clin Chim Acta. 104:401-404.
  • Jenkins DJ; Wolever TM; Nineham R; Sarson DL; Bloom SR; Ahern J; Alberti KG; Hockaday TD. (Jul 1980). Improved glucose tolerance four hours after taking guar with glucose. Diabetologia. 19:21-24.
  • Jenkins DJ; Bloom SR; Albuquerque RH; Leeds AR; Sarson DL; Metz GL; Alberti KG. (Jul 1980). Pectin and complications after gastric surgery: normalisation of postprandial glucose and endocrine responses. Gut. 21:574-579.
  • Adrian TE; Greenberg GR; Barnes AJ; Christofides ND; Alberti KG; Bloom SR. (Jun 1980). Effects of pancreatic polypeptide on motilin and circulating metabolites in man. Eur J Clin Invest. 10:235-240.
  • Foster KJ; Alberti KG; Binder C; Hinks L; Karran S; Smythe P; Talbot S; Turnell D; et alOrskov H. (Jun 1980). Metabolic effects of the use of protein-sparing infusions in postoperative patients. Clin Sci (Lond). 58:507-515.
  • Stubbs SM; Brudenell JM; Pyke DA; Watkins PJ; Stubbs WA; Alberti KG. (24 May 1980). Management of the pregnant diabetic: home or hospital, with or without glucose meters?. Lancet. 1:1122-1124.
  • Pickup JC; Keen H; White MC; Kohner EM; Parsons JA; Alberti KG. (May 1980). [Subcutaneous infusion of insulin in diabetics: clinical results]. Journ Annu Diabetol Hotel Dieu. 17-22.
  • Skyler JS; Alberti KG. (Mar 1980). Clinical assessment of metabolic control in insulin-dependent diabetes mellitus. Diabetes Care. 3:369-370.
  • Pickup JC; Keen H; Viberti GC; White MC; Kohner EM; Parsons JA; Alberti KG. (Mar 1980). Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care. 3:290-300.
  • Frølund L; Kehlet H; Christensen NJ; Alberti KG. (Mar 1980). Effect of ketone body infusion on plasma catecholamine and substrate concentrations during acute hypoglycemia in man. J Clin Endocrinol Metab. 50:557-559.
  • Alberti KG; Batstone GF; Foster KJ; Johnston DG. (Mar 1980). Relative role of various hormones in mediating the metabolic response to injury. JPEN J Parenter Enteral Nutr. 4:141-146.
  • Alberti KG. (2 Feb 1980). The clinical chemist and the future. Br Med J. 280:329.
  • Nattrass M; Sizer K; Alberti KG. (Feb 1980). Correlation of plasma phenformin concentration with metabolic effects in normal subjects. Clin Sci (Lond). 58:153-155.
  • Asplin CM; Hartog M; Goldie DJ; Smythe P; Alberti KG. (Feb 1980). The role of insulin absorption and sensitivity in determining a diabetic's daily insulin dosage. Acta Endocrinol (Copenh). 93:190-195.
  • Keen H; Jarrett RJ; Alberti KG. (Jan 1980). Diabetes mellitus: a new look at diagnostic criteria. Diabetologia. 18:81.
  • Datta H; Stubbs WA; Alberti KG. (1980). Substrate utilization by the lung. Ciba Found Symp. 78:85-104.
  • Stubbs WA; Alberti KG. (1980). The lung, whole-body metabolism and disease. Ciba Found Symp. 78:351-372.
  • Foster KJ; Brown MS; Alberti KG; Buchanan RB; Dewar P; Karran SJ; Price CP; Wood PJ. (Jan 1980). The metabolic effects of abdominal irradiation in man with and without dietary therapy with an elemental diet. Clin Radiol. 31:13-17.
  • Madsbad S; Alberti KG; Binder C; Burrin JM; Faber OK; Krarup T; Regeur L. (17 Nov 1979). Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J. 2:1257-1259.
  • Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG. (3 Nov 1979). Combined use of guar and acarbose in reduction of postprandial glycaemia. Lancet. 2:924-927.
  • Alberti KG. (Nov 1979). The state of the Journal. Diabetologia. 17:265-266.
  • Pickup JC; White MC; Keen H; Parsons JA; Alberti KG. (27 Oct 1979). Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet. 2:870-873.
  • Worth R; Johnston DG; Anderson J; Alberti KG. (6 Oct 1979). Performance of blood-glucose strips. Lancet. 2:742.
  • Datta H; Alberti KG. (Oct 1979). Substrate utilization by the isolated perfused rat lung [proceedings]. Biochem Soc Trans. 7:1026-1028.
  • Whittaker J; Alberti KG; York DA; Singh J. (Oct 1979). The effects of chronic hyperinsulinaemia on insulin binding and glucose metabolism in rat adipocytes. Biochem Soc Trans. 7:1055-1056.
  • De Silva SR; Betteridge DJ; Shawe JE; Cudworth AG; Alberti KG. (Sep 1979). Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment. Diabete Metab. 5:223-229.
  • Kehlet H; Brandt MR; Hansen AP; Alberti KG. (Aug 1979). Effect of epidural analgesia on metabolic profiles during and after surgery. Br J Surg. 66:543-546.
  • Morgan LM; Goulder TJ; Tsiolakis D; Marks V; Alberti KG. (Aug 1979). The effect of unabsorbable carbohydrate on gut hormones. Modification of post-prandial GIP secretion by guar. Diabetologia. 17:85-89.
  • Alberti KG; Thomas DJ. (Jul 1979). The management of diabetes during surgery. Br J Anaesth. 51:693-710.
  • Pickup JC; Keen H; Parsons JA; Alberti KG; Rowe AS. (16 Jun 1979). Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics. Lancet. 1:1255-1257.
  • Pickup JC; Keen H; Parsons JA; Alberti KG. (Jun 1979). Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days. Diabetologia. 16:385-389.
  • Rosson JW; Foster KJ; Walton RJ; Monro PP; Taylor TG; Alberti KG. (2 May 1979). Hair chromium concentrations in adult insulin-treated diabetics. Clin Chim Acta. 93:299-304.
  • Keen H; Jarrett RJ; Alberti KG. (May 1979). Diabetes mellitus: a new look at diagnostic criteria. Diabetologia. 16:283-285.
  • Wolever TM; Jenkins DJ; Nineham R; Alberti KG. (May 1979). Guar gum and reduction of post-prandial glycaemia: effect of incorporation into solid food, liquid food, and both. Br J Nutr. 41:505-510.
  • Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG. (May 1979). Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetice. Horm Metab Res. 11:332-337. DOI.
  • Asplin CM; Hartog M; Goldie DJ; Alberti KG; Binder C; Faber OK. (Apr 1979). Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion. Q J Med. 48:343-360.
  • Foster KJ; Alberti KG; Binder C; Hinks L; Karran S; Orskov H; Smythe P; Talbot S; et alTurnell D. (Apr 1979). Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg. 66:242-245.
  • Walton RJ; Sherif IT; Noy GA; Alberti KG. (27 Jan 1979). Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor. Br Med J. 1:220-221.
  • Alberti KG; Goulder TJ. (1979). [Dietary fiber and diabetes mellitus, a British experience]. Journ Annu Diabetol Hotel Dieu. 289-298.
  • Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG. (1979). Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system. Horm Metab Res Suppl. 202-204.
  • Alberti KG; Nosadini R; Noy G; Kurtz AB. (1979). Differential response of insulin-dependent diabetics to infusions of bovine and highly-purified porcine insulins: a preliminary report. Adv Exp Med Biol. 119:329-335.
  • Nattrass M; Alberti KG; Buckle AL; Cluett B; Jaspan JB; Noy GA; Stubbs WA; Walton R. (1979). Metabolic studies during normoglycaemic clamping of insulin-dependent diabetics using a glucose-controlled insulin infusion system. Horm Metab Res Suppl. 86-92.
  • Pickup JC; Keen H; Parsons JA; Alberti KG. (1979). Newer insulin delivery systems: continuous subcutaneous insulin infusion. Adv Exp Med Biol. 119:491-495.
  • Hansen AP; Hansen HE; Orskov H; Nosadini R; Noy G; Alberti KG. (1979). Normalisation of growth hormone hypersecretion in uraemic diabetics and non-diabetics. Studies with artificial pancreas and artificial kidney. Proc Eur Dial Transplant Assoc. 16:194-197.
  • Pickup JC; Keen H; Parsons JA; Alberti KG. (1979). Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion. Horm Metab Res Suppl. 49-51.
  • Stubbs WA; Delitala G; Jones A; Jeffcoate WJ; Edwards CR; Ratter SJ; Besser GM; Bloom SR; et alAlberti KG. (9 Dec 1978). Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet. 2:1225-1227.
  • Cuthbert C; Alberti KG. (Dec 1978). Acidemia and insulin resistance in the diabetic ketoacidotic rat. Metabolism. 27:1903-1916.
  • Cuthbert C; Alberti KG. (1 Dec 1978). Combined enzymatic assays for 3-hydroxybutyrate and lactate: end-point and kinetic methods. Clin Chim Acta. 90:179-186.
  • Pickup JC; Keen H; Stevenson RW; Parsons JA; Alberti KG; White M; Kohner EM. (4 Nov 1978). Insulin via continuous subcutaneous infusion. Lancet. 2:988-989.
  • Alberti KG. (Nov 1978). Controversies in diabetes. Diabetologia. 15:359-360.
  • Goulder TJ; Alberti KG; Jenkins DA. (Nov 1978). Effect of added fiber on the glucose and metabolic response to a mixed meal in normal and diabetic subjects. Diabetes Care. 1:351-355.
  • Noy GA; Buckle AL; Alberti KG. (2 Oct 1978). Continuous monitoring in vivo of blood glucose, lactate, alanine and 3-hydroxybutyrate. Clin Chim Acta. 89:135-144.
  • Goulder TJ; Alberti KG. (Oct 1978). Dietary fibre and diabetes. Diabetologia. 15:285-287.
  • Lloyd B; Burrin J; Smythe P; Alberti KG. (Oct 1978). Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem. 24:1724-1729.
  • Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK. (Sep 1978). A comparison between diabetics receiving a high or low daily insulin dosage. Horm Metab Res. 10:365-369. DOI.
  • Foster KJ; Alberti KG; Hinks L; Lloyd B; Postle A; Smythe P; Turnell DC; Walton R. (Sep 1978). Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations. Clin Chem. 24:1568-1572.
  • Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG. (Sep 1978). Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics. Diabete Metab. 4:175-180.
  • Johnston DG; Gill A; Hanson R; Alberti KG; Batstone G; Orskov H. (Sep 1978). Somatostatin: a tool for investigation of the metabolic effects of cortisol and glucagon. Metabolism. 27:1445-1447.
  • Nattrass M; Alberti KG; Dennis KJ; Gillibrand PN; Letchworth AT; Buckle AL. (26 Aug 1978). A glucose-controlled insulin infusion system for diabetic women during labour. Br Med J. 2:599-601.
  • Alberti KG; Nattrass M. (Aug 1978). Highly purified insulins. Diabetologia. 15:77-80.
  • Foster KJ; Alberti KG; Allen N; Jenkins J; MacIver JA; Smart CJ; Karran SJ. (Aug 1978). The influence of early post-operative intravenous nutrition upon recovery after total cystectomy. Br J Urol. 50:319-323.
  • Alberti KG; Nattrass M. (Jul 1978). Severe diabetic ketoacidosis. Med Clin North Am. 62:799-814.
  • Barnes AJ; Kohner EM; Bloom SR; Johnston DG; Alberti KG; Smythe F. (3 Jun 1978). Importance of pituitary hormones in aetiology of diabetic ketoacidosis. Lancet. 1:1171-1174.
  • Nattrass M; Todd PG; Turnell D; Alberti KG. (Jun 1978). Metabolic abnormalities during combined sulphonylurea and phenformin therapy in maturity-onset diabetics. Diabetologia. 14:389-395.
  • Jenkins DJ; Wolever TM; Leeds AR; Gassull MA; Haisman P; Dilawari J; Goff DV; Metz GL; et alAlberti KG. (27 May 1978). Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J. 1:1392-1394.
  • Stevenson RW; Parsons JA; Alberti KG. (Apr 1978). Insulin infusion into the portal and peripheral circulations of unanaesthetized dogs. Clin Endocrinol (Oxf). 8:335-347.
  • Nattrass M; Arthur MJ; Smythe P; McGill JI; Todd PG; Alberti KG. (Mar 1978). Hyperlactatemia in diabetics with retinopathy during combined sulphonylurea and phenformin therapy. Diabete Metab. 4:1-4.
  • Nattrass M; Alberti KG. (Feb 1978). Biguanides. Diabetologia. 14:71-74.
  • Thomas DJ; Alberti KG. (Feb 1978). Hyperglycaemic effects of Hartmann's solution during surgery in patients with maturity onset diabetes. Br J Anaesth. 50:185-188.
  • Pickup JC; Keen H; Parsons JA; Alberti KG. (28 Jan 1978). Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J. 1:204-207.
  • Alberti KG; Datta H; Kelly DM; Morgan I; Stubbs WA. (1978). Carbohydrate metabolism in the lung. Biochem Soc Trans. 6:527-530.
  • Alberti KG; Johnston DG; Gill A; Barnes AJ; Orskov H. (1978). Hormonal regulation of ketone-body metabolism in man. Biochem Soc Symp. 163-182.
  • Alberti KG; Nattrass M; Holloway PA. (26 Nov 1977). Dichloroacetate in biguanide-induced lacticacidosis. Lancet. 2:1136.
  • Alberti KG. (Oct 1977). Low-dose insulin in the treatment of diabetic ketoacidosis. Arch Intern Med. 137:1367-1376.
  • Jenkins DJ; Leeds AR; Houston H; Hinks L; Alberti KG; Cummings JH. (Sep 1977). Carbohydrate tolerance in man after six weeks of pectin administration. Proc Nutr Soc. 36:60A.
  • Batstone GF; Alberti KG; Dewar AK. (Sep 1977). Reversible lactic acidosis associated with repeated intravenous infusions of sorbitol and ethanol. Postgrad Med J. 53:567-569.
  • Stubbs WA; Morgan I; Lloyd B; Alberti KG. (Sep 1977). The effect of insulin on lung metabolism in the rat. Clin Endocrinol (Oxf). 7:181-184.
  • Alberti KG; Thomas DJ; Thomas JM. (23 Jul 1977). Control of blood glucose in labour. Br Med J. 2:266-267.
  • Alberti KG; Nattrass M. (2 Jul 1977). Lactic acidosis. Lancet. 2:25-29.
  • Alberti KG; Hockaday TD. (Jul 1977). Diabetic coma: a reappraisal after five years. Clin Endocrinol Metab. 6:421-455.
  • Thomas DJ; Dove AF; Alberti KG. (Jul 1977). Metabolic effects of salbutamol infusion during premature labour. Br J Obstet Gynaecol. 84:497-499.
  • Alberti KG; Nattrass M. (Jun 1977). The physiological function of glucagon. Eur J Clin Invest. 7:151-154.
  • Nattrass M; Todd PG; Hinks L; Lloyd B; Alberti KG. (Apr 1977). Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia. 13:145-152.
  • Alberti KG; Johnston DG. (Apr 1977). Cortisol and catabolism: a new perspective. Clin Sci Mol Med. 52:333-336.
  • Johnston DG; Johnson GA; Alberti KG. (1977). Hepatotrophic factors: implications for diabetes mellitus. Ciba Found Symp. 357-373.
  • Johnson DG; Alberti KG; Faber OK; Binder C. (1 Jan 1977). Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?. Lancet. 1:10-13.
  • STUBBS WA; PALACIO AL; STERLING GM; ALBERTI KG. (1 Jan 1977). METABOLIC EFFECTS OF CHRONIC LUNG-DISEASE. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 7:239-239. Author weblink.
  • Barnes AJ; Bloom SR; Mashiter K; Alberti KG; Smythe P; Turnell D. (Jan 1977). Persistent metabolic abnormalities in diabetes in the absence of glucagon. Diabetologia. 13:71-75.
  • Alberti KG. (1977). The biochemical consequences of hypoxia. J Clin Pathol Suppl (R Coll Pathol). 11:14-20.
  • Johnson GA; Alberti KG. (1977). The metabolic effects of sodium dichloroacetate in experimental hepatitis in the rat [proceedings]. Biochem Soc Trans. 5:1387-1389.
  • Johnston DG; Alberti KG. (Nov 1976). Carbohydrate metabolism in liver disease. Clin Endocrinol Metab. 5:675-702.
  • Bloom SR; Barnes AJ; Bryant MG; Alberti KG. (Nov 1976). Plasma glucagon in diabetes resulting from total pancreatectomy [proceedings]. Metabolism. 25:1481-1482.
  • Marks V; Alberti KG. (Nov 1976). Selected tests of carbohydrate metabolism. Clin Endocrinol Metab. 5:805-820.
  • Jenkins DJ; Goff DV; Leeds AR; Alberti KG; Wolever TM; Gassull MA; Hockaday TD. (24 Jul 1976). Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia. Lancet. 2:172-174.
  • Alberti KG. (May 1976). [Insulin resistance and diabetic ketoacidosis]. Journ Annu Diabetol Hotel Dieu. 79-90.
  • Leeds A; Gassull MA; Jenkins DJ; Alberti KG. (10 Apr 1976). Letter: Metabolic effects of bran. Br Med J. 1:900-901.
  • Alberti KG; Weeks BF. (Mar 1976). A potential screening test for elevated serum amylase levels: preliminary communication. Ann Clin Biochem. 13:361-363.
  • Lundbaek K; Hansen AP; Orskov H; Christensen SE; Iversen J; Seyer-Hansen K; Alberti KG; Whitefoot R. (31 Jan 1976). Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet. 1:215-218.
  • Stubbs WA; Alberti KG; Woods HF; Teddy PJ. (13 Dec 1975). Letter: Age-dependent sensitivity to salicylate. Lancet. 2:1216.
  • Braybrooke J; Lloyd B; Nattrass M; Alberti KG. (Nov 1975). Blood sampling techniques for lactate and pyruvate estimation: a reappraisal. Ann Clin Biochem. 12:252-254.
  • Record CO; Chase RA; Alberti KG; Williams R. (Nov 1975). Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose. Clin Sci Mol Med. 49:473-479.
  • Barnes AJ; Bloom A; Crowley MF; Tuttlebee JW; Bloom SR; Alberti KG; Smythe P; Turnell D. (18 Oct 1975). Is glucagon important in stable insulin-dependent diabetics?. Lancet. 2:734-737.
  • Alberti KG. (20 Sep 1975). Letter: Intravenous insulin boluses in treatment of diabetic coma. Lancet. 2:547-548.
  • Christensen NJ; Alberti KG; Brandsborg O. (12 Sep 1975). Plasma catecholamines and blood substrate concentrations: studies in insulin induced hypoglycaemia and after adrenaline infusions. Eur J Clin Invest. 5:415-423.
  • Blackshear PJ; Holloway PA; Alberti KG. (Sep 1975). Factors regulating amino acid release from extrasplanchnic tissues in the rat. Interactions of alanine and glutamine. Biochem J. 150:379-387.
  • Alberti KG. (Sep 1975). The future of the measurement of intermediary metabolites in clinical medicine. Ann Clin Biochem. 12:192-195.
  • Alberti KG. (14 Jun 1975). Role of glucagon and other hormones in development of diabetic ketoacidosis. Lancet. 1:1307-1311.
  • Alberti KG; Dornhorst A; Rowe AS. (Jun 1975). Metabolic rhythms in normal and diabetic man. Studies in insulin-treated diabetes. Isr J Med Sci. 11:571-580.
  • Backshear PJ; Holloway PA; Alberti KG. (Feb 1975). Metabolic interactions of dichloroacetate and insulin in experimental diabetic ketoacidosis. Biochem J. 146:447-456.
  • Smith R; Fuller DJ; Wedge JH; Williamson DH; Alberti KG. (4 Jan 1975). Initial effect of injury on ketone bodies and other blood metabolites. Lancet. 1:1-3.
  • RECORD CO; CHASE RA; ALBERTI KG; WILLIAMS R. (1 Jan 1975). GLUCOSE HOMEOSTASIS IN PATIENTS WITH PARACETAMOL-INDUCED LIVER-DAMAGE. DIGESTION. 12:341-342. Author weblink.
  • Alberti KG; Dornhorst A; Rowe AS. (1975). Metabolic rhythms in old age. Biochem Soc Trans. 3:132-133.
  • Alberti KG; Cohen RD; Woods HF. (21 Dec 1974). Lactic acidosis and hyperlactataemia. Lancet. 2:1519-1560.
  • Ball S; Woods HF; Alberti KG. (21 Dec 1974). Lacticacidosis, ketoacidosis, and hyperalaninaemia in a phenformintreated diabetic patient. Br Med J. 4:699-700.
  • Blackshear PJ; Holloway PA; Alberti KG. (15 Nov 1974). The effects of starvation and insulin on the release of gluconeogenic substrates from the extra-splanchnic tissues in vivo. FEBS Lett. 48:310-313.
  • Woods HF; Stubbs WA; Johnson G; Alberti KG. (Nov 1974). Inhibition by salicylate of gluconeogenesis in the isolated perfused rat liver. Clin Exp Pharmacol Physiol. 1:535-540.
  • Rowe AS; Dornhorst A; Alberti KG. (Sep 1974). Proceedings: Metabolic rhythms: variation with age. Clin Sci Mol Med. 47:15P.
  • Alberti KG; Hockaday TD; Turner RC. (31 Aug 1974). Letter: Small doses of insulin in the treatment of diabetic "coma". Lancet. 2:524-525.
  • Cohen RD; Woods HF; Alberti KG. (17 Aug 1974). Letter: Lactic acidosis and hyperlactataemia. Lancet. 2:405.
  • Aynsley-Green A; Baum JD; Alberti KG; Woods HF. (Aug 1974). Hyperlactataemia during intravenous feeding in childhood. Arch Dis Child. 49:647-653.
  • Blackshear PJ; Holloway PA; Alberti KG. (Aug 1974). The metabolic effects of sodium dichloroacetate in the starved rat. Biochem J. 142:279-286.
  • Page MM; Alberti KG; Greenwood R; Gumaa KA; Hockaday TD; Lowy C; Nabarro JD; Pyke DA; et alSönksen PH; Watkins PJ; West TE. (29 Jun 1974). Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J. 2:687-690.
  • Aynsley-Green A; Alberti KG. (Mar 1974). In vivo stimulation of insulin secretion by guanidine derivatives in the rat. Horm Metab Res. 6:115-120. DOI.
  • Blackshear PJ; Alberti KG. (Jan 1974). Experimental diabetic ketoacidosis. Sequential changes of metabolic intermediates in blood, liver, cerebrospinal fluid and brain after acute insulin deprivation in the streptozotocin-diabetic rat. Biochem J. 138:107-117.
  • Alberti KG; Young JD; Hockaday TD. (Jan 1974). Werner's syndrome: metabolic observations. Proc R Soc Med. 67:36-38.
  • Alberti KG; Christensen NJ; Christensen SE; Hansen AP; Iversen J; Lundbaek K; Seyer-Hansen K; Orskov H. (8 Dec 1973). Inhibition of insulin secretion by somatostatin. Lancet. 2:1299-1301.
  • Alberti KG. (Dec 1973). Blood metabolites in the diagnosis and treatment of diabetes mellitus. Postgrad Med J. 49:Suppl 7:955-63.
  • Record CO; Alberti KG; Williamson DH; Wright R. (Nov 1973). Glucose tolerance and metabolic changes in human viral hepatitis. Clin Sci Mol Med. 45:677-690.
  • Alberti KG; Hockaday TD; Turner RC. (8 Sep 1973). Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet. 2:515-522.
  • Aynsley-Green A; Biebuyck JF; Alberti KG. (Aug 1973). Anaesthesia and insulin secretion: the effects of diethyl ether, halothane, pentobarbitone sodium and ketamine hydrochloride on intravenous glucose tolerance and insulin secretion in the rat. Diabetologia. 9:274-281.
  • Alberti KG; Hockaday TD. (Feb 1973). Serum growth hormone in diabetic coma. Postgrad Med J. 49 Suppl 1:141-143.
  • ALBERTI KG; HOCKADAY TD. (1 Jan 1973). DIABETIC COMA - SERUM GROWTH-HORMONE BEFORE AND DURING TREATMENT. DIABETOLOGIA. 9:13-19. Author weblink DOI.
  • AYNSLEYG A; ALBERTI KG. (1 Jan 1973). DIURETICS AND CARBOHYDRATE METABOLISM - EFFECTS OF FUROSEMIDE AND AMILORIDE ON BLOOD-GLUCOSE, PLASMA-INSULIN AND CATIONS IN RAT. DIABETOLOGIA. 9:34-42. Author weblink DOI.
  • RECORD CO; ALBERTI KG. (1 Jan 1973). GLUCOSE-TOLERANCE AND BLOOD METABOLITE CHANGES IN GALACTOSAMINE HEPATITIS AND OBSTRUCTIVE-JAUNDICE IN RAT. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 3:130-135. Author weblink DOI.
  • Aynsley-Green A; Alberti KG. (Jan 1973). The importance of the guanidine group in the insulin-stimulatory effect of amiloride hydrochloride. Horm Metab Res. 5:55. DOI.
  • Alberti KG; Hockaday TD. (Jan 1973). Thiazides and hypokalaemia in diabetic ketoacidosis. Postgrad Med J. 49:29-31.
  • Woods HF; Alberti KG. (23 Dec 1972). Dangers of intravenous fructose. Lancet. 2:1354-1357.
  • Hockaday TD; Alberti KG. (Nov 1972). Diabetic coma. Clin Endocrinol Metab. 1:751-788.
  • Record CO; Alberti KG; Williamson DH. (Nov 1972). Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration. Biochem J. 130:37-44.
  • Alberti KG. (Oct 1972). Gluconeogensis in liver disease. Conn Med. 36:568-571.
  • Alberti KG; Emerson PM; Darley JH; Hockaday TD. (26 Aug 1972). 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet. 2:391-395.
  • Alberti KG; Hockaday TD. (3 Jun 1972). Rapid blood ketone body estimation in the diagnosis of diabetic ketoacidosis. Br Med J. 2:565-568.
  • Alberti KG; Record CO; Williamson DH; Wright R. (May 1972). Metabolic changes in active chronic hepatitis. Clin Sci. 42:591-605.
  • Alberti KG; Hockaday TD; Williamson DH. (May 1972). Metabolic effects of chronic caffeine administration in a patient with diabetes mellitus. Proc R Soc Med. 65:485-486.
  • Alberti KG; Emerson PM; Darley JH; Hockaday TD. (15 Apr 1972). Red cell 2,3-diphosphoglycerate and diabetes. Lancet. 1:843-844.
  • Aynsley-Green A; Alberti KG. (5 Feb 1972). Serum-insulin or plasma-insulin?. Lancet. 1:318-319.
  • Alberti KG; Oxbury JM; Higgins G. (8 Jan 1972). Factitious hypoglycaemia: chlorpropamide self-administration by a non-diabetic. Br Med J. 1:87-88.
  • Biebuyck JF; Alberti KG. (Jan 1972). The effects of anaesthetic agents on carbohydrate metabolism in the rat. Clin Sci. 42:4P-5P.
  • Hawkins RA; Alberti KG; Houghton CR; Williamson DH; Krebs HA. (Nov 1971). The effect of acetoacetate on plasma insulin concentration. Biochem J. 125:541-544.
  • Record CO; Alberti KG; Williamson DH. (Oct 1971). Lipid metabolism in experimental cholestasis. Biochem J. 124:56P.
  • Schein PS; Alberti KG; Williamson DH. (Sep 1971). Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology. 89:827-834.
  • Alberti KG; Ilic V; Record C; Williamson DH; Wright R. (Aug 1971). Metabolic abnormalities in patients with active chronic hepatitis. Clin Sci. 41:4P.
  • Alberti KG; Shahriari AA; Levine HD; Lauler DP. (Apr 1971). Reversal of ouabain-induced arrhythmias in the dog by intravenous arginine hydrochloride. Cardiovasc Res. 5:226-235.
  • Alberti KG; Corbett J; Hockaday TD; Williamson DH. (2 Jan 1971). Lactic acidosis. Br Med J. 1:47-48.
  • Alberti KG; Schein PS; Houghton CR; Williamson DH. (Dec 1970). Experimental studies with glibenclamide in the rat. Postgrad Med J. Suppl:9-15.
  • Alberti KG; Sharp GW. (Dec 1970). Identification of four types of steroid by their interaction with mineralocorticoid receptors in the toad bladder. J Endocrinol. 48:563-574.
  • Alberti KG; Sharp GW. (1970). The isolation of bound aldosterone from the nuclei of human, toad and rat colon. Ann Endocrinol (Paris). 31:Suppl 4:777+.
  • Alberti KG; Sharp GW. (Dec 1969). Four classes of steroid identified by their interaction with mineralocorticoid receptors in the toad bladder. Biochem J. 115:45P.
  • Alberti KG; Sharp GW. (18 Nov 1969). Macromolecular binding of aldosterone in the toad bladder. Biochim Biophys Acta. 192:335-346.
  • Alberti KG; Bartley W. (Mar 1969). The localization of proteolytic activity in rat liver mitochondria and its relation to mitochondrial swelling and aging. Biochem J. 111:763-776.
  • Alberti KG; Sharp GW. (Dec 1968). Nuclear binding of aldosterone in toad bladder. Biochem J. 110:42P-43P.
  • ALBERTI KG; MIDDLETON GG; CAIRD FI. (14 Aug 1965). THE ACCURACY OF DEXTROSTIX IN THE ESTIMATION OF BLOOD-SUGAR. Lancet. 2:319-321.
  • ALBERTI KG; BARTLEY W. (Jun 1965). FURTHER OBSERVATIONS ON THE PRODUCTION OF AMINO ACIDS BY RAT-LIVER MITOCHONDRIA AND OTHER SUBCELLULAR FRACTIONS. Biochem J. 95:641-656.
  • ALBERTI KG; BARTLEY W. (Apr 1963). The production of amino acids by cell fractions, particularly rat-liver mitochondria. Biochem J. 87:104-114.

Chapters in books

  • Alberti KG; Tattersall RB. Diabetes mellitus. 235-236. (2001).
  • Alberti KG. Diabetic acidosis, hypersmolar coma, and lactic acidosis. 3rd:1438-1451. (2001).

Conferences

  • Gray CS; Hildreth AJ; O'Connell JE; Johnston DE; Alberti KG. Maintaining euglycemia following stroke: The hypotensive effect of glucose potassium insulin infusions upon blood pressure - the Glucose Insulin in Stroke Trial experience. International Stroke Conference, 16 Feb 2006 - 18 Feb 2006. 37:635-635. LIPPINCOTT WILLIAMS & WILKINS (1 Feb 2006). Author weblink.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook